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ABSTRACT  
   
The study of bacterial resistance to antimicrobial peptides (AMPs) is a significant 
area of interest as these peptides have the potential to be developed into alternative drug 
therapies to combat microbial pathogens. AMPs represent a class of host-mediated 
factors that function to prevent microbial infection of their host and serve as a first line of 
defense. To date, over 1,000 AMPs of various natures have been predicted or 
experimentally characterized. Their potent bactericidal activities and broad-based target 
repertoire make them a promising next-generation pharmaceutical therapy to combat 
bacterial pathogens.   
It is important to understand the molecular mechanisms, both genetic and physiological, 
that bacteria employ to circumvent the bactericidal activities of AMPs. These 
understandings will allow researchers to overcome challenges posed with the 
development of new drug therapies; as well as identify, at a fundamental level, how 
bacteria are able to adapt and survive within varied host environments.  
Here, results are presented from the first reported large scale, systematic screen in which 
the Keio collection of ~4,000 Escherichia coli  deletion mutants were challenged against 
physiologically significant AMPs to identify genes required for resistance. Less than 3% 
of the total number of genes on the E. coli chromosome was determined to contribute to 
bacterial resistance to at least one AMP analyzed in the screen. Further, the screen 
implicated a single cellular component (enterobacterial common antigen, ECA) and a 
single transporter system (twin-arginine transporter, Tat) as being required for resistance 
to each AMP class.  
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Using antimicrobial resistance as a tool to identify novel genetic mechanisms, subsequent 
analyses were able to identify a two-component system, CpxR/CpxA, as a global 
regulator in bacterial resistance to AMPs. Multiple previously characterized CpxR/A 
members, as well as members found in this study, were identified in the screen. Notably, 
CpxR/A was found to transcriptionally regulate the gene cluster responsible for the 
biosynthesis of the ECA. Thus, a novel genetic mechanism was uncovered that directly 
correlates with a physiologically significant cellular component that appears to globally 
contribute to bacterial resistance to AMPs. 
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INTRODUCTION 
S. enterica serovar Typhimurium and Escherichia coli are classic representatives of the 
Enterobacteriaceae family of Gram-negative, rod-shaped bacteria. While most enterics 
remain harmless to their host, i.e., maintain a synergistic rather than an antagonistic 
relationship and likely persist as part of the normal flora (e.g., E. coli), others (e.g., S. 
typhimurium) can invade host cells and cause disease. Regardless of the relationship, 
these microbes encounter an array of toxic host-mediated factors, such as antimicrobial 
peptides, and a variety of intracellular environments that threaten their livelihoods. 
Nevertheless, bacteria have developed mechanisms in which various chromosomally 
encoded systems are employed to evade these host factors and conditions, allowing for 
survival and adaptation in host environments.  
Importance of two-component systems 
Microbial mechanisms of intracellular survival and adaptation are often mediated by 
chromosomally encoded two-component systems (TCS). These phosphotransfer systems 
consist of a histidine kinase sensor which, upon activation by a specific signal 
molecule(s), will phosphorylate its cognate response regulator. The active regulator can 
then bind to target promoters, with a higher affinity than the non-active form, to activate 
or repress gene transcription (1). Sensors are often bifunctional and contain phosphatase 
activity so that when the signal level is brought to non-activating concentrations, the 
phosphatase can inactivate its regulator by dephosphorylation. In this case, the abundance 
of the signaling molecule modulates the sensor kinase and phosphatase activities which 
will determine the phosphorylation level of the regulator (2). Additionally, an intrinsic 
positive feedback mechanism is found with most of these systems to modulate the 
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amount of phosphorylated regulator in the absence of the signal, as seen with the classic 
TCS PhoP/PhoQ (3). In the presence of the signal, low Mg
2+
, PhoQ will phosphorylate 
PhoP which in turn binds to target promoters, including its own to generate more PhoQ 
and PhoP, thus establishing autoregulation via positive feedback. The autoregulatory 
capabilities have been shown to allow for temporal increase in gene expression, as in 
Bacillus subtilis sporulation (4), but also to cause an instant abundance in 
phosphorylation of the response regulator, as in Salmonella PhoP/PhoQ (5). Of course 
TCS can be more extensive and complex than just described, including: (i) the use of 
multiple phosphotransfers in a single system (referred to as phosphorelays) which is 
predicted to provide control points to avoid activation of regulators during inopportune 
times; (ii) the presence of branched phosphorylation pathways that can have multiple 
phosphoryl sources or targets which allows for a more integrated approach to signal 
transduction; and (iii) an additional ability to integrate signals in multiple TCS pathways 
via cross-phosphorylation (referred to as cross-talk) (reviewed in (6)). Thus, it is apparent 
that sophisticated systems are in place to mediate bacterial survival in host environments. 
The PhoP/PhoQ two-component system 
The Salmonella and E. coli PhoP/PhoQ TCS has been well studied and characterized as a 
model system (reviewed in (7)). PhoP/Q mediates virulence and host adaptation by 
responding to components of the host environment, such as low extracellular Mg
2+
, Mn
2+
, 
and Ca
2+
, as well as low pH, and host-secreted antimicrobial peptides. 
PhoP/Q can also activate another TCS, PmrA/PmrB (8), by stimulating expression of 
pmrD whose gene product post-transcriptionally activates PmrA/B. Thus, several PhoP-
dependent genes are also regulated by PmrA/B in response to extracytoplasmic Fe
3+
 (9).  
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Both PhoP/Q and PmrA/B have been shown to mediate Salmonella and E. coli resistance 
to antimicrobial peptides (discussed below) further demonstrating their contributions to 
survival and adaptation in host environments. 
The CpxR/CpxA two-component system 
The E. coli CpxR/CpxA TCS represents one of three characterized stress response 
systems, including BaeRS and σE, that work coordinately and individually to maintain 
cell envelope integrity under various harsh extracytoplasmic conditions (reviewed in 
(10)). The cpxRA operon encodes a sensor histidine kinase/phosphatase, CpxA, and its 
cognate response regulator, CpxR, that globally regulate a vast number of promoters in 
response to periplasmic stress caused by misfolded proteins, inner membrane disruptions, 
alkaline pH, starvation, and high osmolarity (reviewed in (10)). CpxR/A has been 
experimentally demonstrated or proposed to regulate transcription of over 150 loci 
(APPENDIX E), including cpxP which encodes a negative regulator of the CpxR/A 
system (11). Upon the generation of misfolded proteins, CpxP is predicted to become 
unbound to the CpxA sensor to bind misfolded proteins and mediate DegP-facilitated 
degradation of the CpxP-misfolded protein complex (12). Thus, CpxR/A becomes 
activated due to the lack of CpxP binding to CpxA.  As the CpxR/A regulon continues to 
expand, the vastness of its circuitries become evident as it continues to be implicated in 
virulence (reviewed in (10)), biofilm formation (13), and chemotaxis (14) therefore 
having a global effect in signal transduction pathways pertaining to bacterial survival 
under stress conditions. Recently, CpxR/A has been demonstrated to facilitate bacterial 
resistance to various classes of antimicrobial substances, including antimicrobial peptides 
(15) and antibiotics (16-20) by upregulating target promoters; meanwhile facilitating the 
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bactericidal effects of peptidoglycan recognition proteins (PGRPs) (21) and certain 
classes of antibiotics, such as aminoglycosides (22). This suggests a dual role of the 
CpxR/A system regarding bactericidal substances: a protector and a facilitator, depending 
on the signal (antimicrobial substance) and magnitude of activation. 
The dual response of CpxR/A to antimicrobials  
Antibiotics represent a major group of antimicrobials, in which there are several classes 
with diverse activities and cellular targets. Aminoglycosides are a class of antibiotics that 
target the 30S ribosomal subunit resulting in mistranslation of proteins due to 
mismatching of tRNAs during translation (23). It is believed that the incorporation of 
mistranslated proteins into the inner membrane ultimately leads to bacterial cell death 
(24).  
CpxR/A-mediated protection against antibiotics. The accumulation of mistranslated 
proteins, and subsequent misfolded proteins caused by aminoglycosides, should generate 
a signal for the sensor kinase, CpxA, which will in turn phosphorylate the response 
regulator, CpxR, to upregulate expression of key target genes. Such genes include degP 
which encodes a periplasmic protease that functions to alleviate the stress of misfolded 
proteins by degrading the protein (25). Transcription of degP is also regulated by an 
additional stress response system, σE, that is generally activated upon perturbations in the 
outer membrane (26), suggesting multiple lines of extracytoplasmic defense mediated by 
DegP. This theory is supported because expression of degP was significantly increased in 
the presence of an aminoglycoside, gentamicin (22), suggesting that this antibiotic 
activates the CpxR/A system and thus its downstream target, degP, which functions to 
(presumably) reduce the load of mistranslated proteins.  However, when the load 
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becomes too great, the CpxR/A system is unable to alleviate the stress resulting in cell 
death. Along these lines, constitutive activation of CpxR/A was recently shown to 
provide E. coli protection against aminoglycosides, likely due to the constitutive 
expression of DegP, but not other classes of antibiotics (20) including fluoroquinolones 
(which inhibit DNA replication) or β-lactams (which inhibit cell wall biosynthesis) 
because they do not perpetuate the production of misfolded outer membrane proteins.  
CpxR/A-facilitated killing by antimicrobials. An alternative explanation regarding the 
bactericidal nature of aminoglycosides suggests that the antibiotics alter the overall 
cellular physiology, disrupting essential processes such as respiration, which ultimately 
leads to the formation of reactive oxygen species (27). While the generation of reactive 
oxygen species has recently been shown to not contribute to antibiotic-dependent killing 
(28, 29), the theory is supported by evidence which demonstrates that aminoglycosides 
stimulate the formation of hydroxyl radicals, however (surprisingly) in a CpxR/A-
dependent manner. Deletion of cpxR or cpxA abolished the formation of hydroxyl 
radicals and reduced antibiotic-induced killing; meanwhile, deletion of degP significantly 
reduced radical formation (22). This was surprising since DegP had been previously 
shown to combat disruptions caused by reactive oxygen species (30). These findings, 
however, are in agreement with the observation that deletion of cpxA could increase 
bacterial resistance to antibiotics (22); although it was presumed to be due to the lack of 
CpxA phosphatase activity, resulting in increased phosphorylated CpxR. In this case, 
constant phosphorylation of CpxR by alternative phosphor donors should activate 
downstream targets to counteract the bactericidal activities of the antibiotic.  Similarly, 
peptidoglycan recognition proteins (PGRPs) have been shown to activate the CpxR/A 
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system to promote their bactericidal effect (21). PGRPs bind the outer membrane of E. 
coli to activate CpxR/A which kills the bacterium by inducing depolarization of the 
membrane (21). Furthermore, ΔcpxA and ΔcpxR mutants were more resistant to PGRPs 
than their isogenic wild-type counterparts (21) providing additional evidence of a role for 
CpxR/A to facilitate antimicrobial killing.  
On the other hand, a deletion mutant of cpxR and cpxA (ΔcpxAR) was more susceptible 
than the wild-type hyper-virulent K1 serotype Klebsiella pneumoniae NTUH-K2044 to 
bile salts, chloramphenicol, and β-lactams (19), further suggesting a protective role of 
CpxR/A in resistance to antimicrobials. Cumulatively, these data suggest a dual role of 
the CpxR/A system regarding bactericidal substances depending on the signal 
(antimicrobial substance) and magnitude of activation. 
The Mar system 
The multidrug-resistant operon, marRAB, encodes a repressor, MarR, an activator, MarA, 
and a protein of unknown function, MarB, which coordinately regulate the mar promoter, 
in concert with global regulators Rob and SoxS, to maintain intrinsic resistance to 
antimicrobial substances.  
The Mar response. The marRAB promoter has been extensively studied and well-
characterized (31-34).  In the presence of specific antibiotics, bile salts, and reactive 
oxygen species, MarA (35) (36), 50), Rob (37, 38), and SoxS (39, 40), respectively, will 
bind to a 20 nucleotide sequence designated as the marbox (33) to activate transcription 
of the operon. In contrast, MarR is a strong repressor that binds at the operator region 
whose effect is only alleviated when a compound, such as salicylate, binds the protein to 
result in a disassociation to the promoter allowing for transcription (31, 32, 41). Recently 
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several salicylate-like aromatic metabolites including 2,3-dihydroxybenzoate (DHB) and 
anthranilate (ANT) in an E. coli wild-type background, and 4-hydroxybenzoate (HBA) in 
a ΔtolC background were shown to activate the mar promoter (42). In addition, DHB was 
found to activate the promoter by directly binding to MarR with a similar affinity as 
salicylate, while ANT and HBA could not, indicating that their efforts are independent of 
MarR.  
Role of Mar in resistance to AMPs. The marRAB operon was shown to be activated by 
sub-lethal concentrations of AMPs via Rob (which is required for polymyxin B-induced 
upregulation of micF (43)) and could facilitate resistance, at least in part, by 
overexpressing the AcrAB/TolC efflux pump (44). While deletion of marA had no 
apparent phenotype regarding susceptibility to AMPs, constitutive expression of marA 
(here, termed marA*) by either a point mutation in marR or a plasmid harboring a wild-
type copy of marA, decreased bacterial susceptibility to multiple AMPs representing 
various classes, including: cathelicidin LL-37, α-defensin human neutrophil peptide-2 
(HNP-2), human β-defensin-1 (HBD-1), and the cyclic lipopeptide polymyxin B (44). 
This effect was dependent on the AcrAB/TolC efflux system since deletion of acrAB or 
tolC abolished the decreased susceptibility to LL-37, HBD-1, and polymyxin B (44). 
Noteworthy, deletion of tolC in the marA* background resulted in higher susceptibility to 
AMPs than deletion of acrAB (44) indicating that an additional TolC-dependent system 
contributes to resistance. Importantly, deletion of tolC resulted in increased susceptibility 
to each AMP analyzed, however, susceptibility to polymyxin B could be reduced in a 
marA* background (44) suggesting that additional MarA-dependent genes contribute to 
bacteria resistance to polymyxin B. Conversely, marA* in a ΔtolC background increased 
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bacterial susceptibility to defensins HNP-2 and HBD-2 when compared to the original 
ΔtolC mutant (44). Thus, MarA can play a protective role as well as a facilitator role, 
depending on the signal, similar to CpxR/A (discussed above).  
The twin-arginine transporter (Tat) system 
The twin-arginine transporter (Tat) system is a Sec-independent system responsible for 
the transport of globular proteins across the inner membrane (45). The Tat system is 
encoded by the chromosomal loci tatA, tatB, and tatC. Although tatD is located within 
the operon, its function with the Tat system remains to be determined (46). Additionally, 
translocation via Tat is facilitated by an accessory protein, TatE, which is not part of the 
tatABCD operon, but appears to be a functional ortholog of TatA. The Tat system has 
many characterized substrates with diverse cellular functions, including ion transport, 
energy metabolism, cell wall biosynthesis, and virulence (reviewed in (47)). As a 
requirement, folded proteins transported by this system must have an N-terminal signal 
peptide that is recognized by the Tat apparatus and cleaved prior to translocation. The 
signal sequence has a polar N-terminal region, an uncharged and hydrophobic region, and 
a C-terminal signal peptidase region that is cleaved before the protein is transported. The 
hallmark of Tat-dependent substrates is the presence of a twin-arginine motif that carries 
two conserved arginine residues within the signal sequence recognized by Tat, 
(S/T)RRxFLK (48), although a couple of Tat-dependent substrates have been 
characterized without the twin-arginine motif (49, 50).  
Deletions of tat genes have pleiotropic effects. In E. coli, such effects include 
mislocalization of peptidoglycan amidases AmiA and AmiC that cause a cell chaining 
phenotype due to the inability to cleave the septum, filamentation, inability to grow 
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anaerobically with certain electron acceptors, and increased membrane permeability (51-
53). Thus, the Tat system has an important role in cell metabolism and survival. 
The enterobacterial common antigen 
Members of the rfe-rff gene cluster encode enzymes required for the biosynthesis of the 
enterobacterial common antigen (ECA), a glycolipid composed of a trisaccharide repeat 
located on the outer leaflet of the outer membrane in all species of the 
Enterobacteriaceae family (reviewed in (54)). The first step in the synthesis of the 
trisaccharide repeat is catalyzed by Rfe in which GlcNAc-1-phosphate is transferred from 
UDP-GlcNAc to undecaprenyl monophosphate to generate lipid I. Next, ManNAcA is 
incorporated to generate lipid II followed by incorporation of Fuc4NAc, via RffC and 
RffT, to generate lipid III. Finally, sequential elongation, via WzzE and WzyE, followed 
by presentation to the outer leaflet of the outer membrane, via WzxE, completes the ECA 
biosynthesis process. ECA has been reported to exist in three forms (54): ECACYC, a 
water-soluble cyclic form that consists of four repeating units; ECALPS, in which the 
trisaccharide repeat is linked to the core region of LPS; and, ECAPG, in which the 
trisaccharide repeat is linked to the outer membrane phosphoglyceride. 
Phenotypic observation of ECA mutants. While the physiological function of ECA 
remains to be determined, it has been implicated in bacterial resistance to bile salts and 
organic acids (55-57), swarming motility (58), and virulence (57). Sensitivity to bile 
salts: Deletion of E. coli rffA (wecE), rffT (wecF), or rffH (rmlA), each of which encodes 
an enzyme involved in the conversion of lipid II to lipid III, resulted in increased 
sensitivity to bile salts as the mutants were unable to grow on MacConkey agar, 
presumably due to the accumulation of the lipid II intermediate (55). Further studies 
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determined that deletion of Salmonella rfe (wecA) and rffC (wecD) caused sensitivity to 
the bile salt deoxycholate (57). This proved that accumulation of lipid II could not be the 
sole cause of increased susceptibility to bile salts and proposed that biosynthesis of ECA 
is required for bacterial resistance to bile salts. Sensitivity to organic acids: Deletion of 
rfe (wecA) and rffE (wecB) in Shiga Toxin-producing E. coli (STEC) O157:H7 NGY9 
rendered cells sensitive to  acetic acid (56), suggesting that ECA is required for bacterial 
resistance to acetic acid. Defect in swarming motility: Deletion of E. coli rfe (wecA), rffE 
(wecB), rffD (wecC), rffG, rffH, rffC (wecD), rffA (wecE), wzx (wzxE), rffT (wecF), or 
rffM (wecG) caused a defect in cell swarming, but not swimming motility (58), indicating 
that ECA plays a significant role in swarming motility. Decrease in virulence: Salmonella 
rfe and rffC mutants were highly attenuated in a mouse model when orally inoculated 
(57) suggesting a protective role of ECA in virulence.  
Peptidoglycan amidases, AmiA and AmiC 
The peptidoglycan matrix, or cell wall, of the bacterial cell envelope is a complex 
structure that ultimately provides support for the accompanying phospholipid membrane. 
Thus, it gives the cell its overall shape and rigidity, as well as provides protection against 
changes in osmotic pressure. The matrix is composed of (i) a backbone that consists of 
polysaccharide strands, N-acetylglucosamine and N-acetylmuramic acid, that are cross 
linked by a β-1,4 glycosidic bond and (ii) a meshwork of peptides that are covalently 
connected to the N-acetylmuramic acid residues by cross-linked peptides to form a matrix 
around the cytoplasmic membrane (59). During bacterial growth and cell division, the 
peptidoglycan is constantly remodeled by synthases and hydrolases that cooperatively 
work to generate and cleave peptide bonds. AmiA and AmiC are N-acetylmuramoyl-L-
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alanine amidases that cleave the bond between the L-alanine amino acid on the peptide 
chain and the N-acetylmuramic acid residue of the peptidoglycan matrix (51, 60). They 
are transported by the Tat system (discussed above, (61)) to the periplasm in which they 
carry out their enzymatic activities. Cells lacking these enzymes form chains as the 
septum is unable to be completely cleaved during daughter cell separation (51). 
Additionally, cells that inhibit the activity of these enzymes such as (i) absence of LytM 
factors EnvC and NlpD that activate the amidases (62) or (ii) absence of the FtsEX cell-
wall hydrolysis regulator (63) exhibit a chaining phenotype, further demonstrating the 
significance of these amidases in cell wall biogenesis. 
Cumulatively, bacteria have developed strategies to evade host-mediated defenses in 
efforts to promote survival and adaptation. The use of multiple, integrated systems is a 
key approach in such defenses. In the upcoming chapters of this dissertation study, the 
importance of the aforementioned systems and cellular components will be further 
discussed in regards to bacterial resistance to antimicrobial peptides. 
Characterization of antimicrobial peptides 
Characteristics of AMPs. Antimicrobial peptides (AMPs) represent a class of host-
mediated factors that function to prevent microbial infection of their host (64). They are 
short peptides (12-100 amino acids) with a net charge between +2 and +7 (65, 66) 
produced by the innate immune system in a variety of organisms, including animal, plant 
and bacterial species, and serve as a first line of defense (67). As such, AMPs exert their 
activities at epithelial surfaces and within specialized phagocytic cells, such as 
macrophages. Due to their amphipathic nature, in which they contain an abundance of 
hydrophobic residues, they are thought to interact with bacterial membranes to 
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subsequently kill cells (reviewed in (68)). To date, over one thousand AMPs have been 
experimentally validated or predicted and can be found in several on-line databases (The 
Antimicrobial Peptide Database, http://aps.unmc.edu/AP/main.php (64); CAMP: 
Collection of Anti-Microbial Peptides, http://www.bicnirrh.res.in/antimicrobial/ (69); 
DAMPD: Dragon Antimicrobial Peptide Database, http://apps.sanbi.ac.za/dampd/). 
Classification of AMPs. Based on their secondary structure, AMPs can be grouped into 
four classes (70), summarized in Table 1: (i) amphipathic peptides that form -helix 
structures upon initial contact with the bacterial membrane, (ii) -sheet peptides that are 
joined by 2-4 disulfide bridges, (iii) extended peptides that generally consist of an 
abundance one or more amino acids, and (iv) loop peptides that are formed by a single 
disulfide bond. -sheet peptides, which include -, - and -defensins (characterized 
from mammals), and amphipathic -helix peptides, which include cathelicidins 
(primarily characterized from mammals), cecropins (characterized from insects), 
magainins (characterized from amphibians) and melittin (characterized from insects), 
make up the majority of the AMPs. In many cases, different classes of peptides and 
different variants within the classes can be found within a single host. In fact, it is rare for 
the same AMP sequence to be characterized from two different hosts even though the 
amino acid sequences may be well conserved in the precursor molecule from which the 
mature AMP is derived.  
α-helix structured AMPs. α-helix structured AMPs are one of the largest and most 
extensively studied groups of AMPs. Upon interaction with phospholipid membranes, 
these disordered peptides fold into an α-helical conformation to either absorb or insert 
into the membrane to exert their activities. 
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Table 1.  Four classes of AMPs based on their structure. 
AMP type Characteristics Examples Sequence Ref 
α-helix 
structured 
peptides 
  
Cecropin A  
(Hyalophora cecropia, moth) 
KWKLFKKIEKVGQNIRDG
IKAGPAVAVVGQATQIAK 
(71) 
Magainin 2  
(Xenopus laevis, toad skin) 
GIGKFLHSAKKFGKAFVG
EIMNS 
(72) 
SMAP29  
(sheep myeloid) 
RGLRRLGRKIAHGVKKYG
PTVLRIIRIAG 
(73) 
LL-37 
(humans, leukocytes, epithelia) 
LLGDFFRKSKEKIGKEFKR
IVQRIKDFLRNLVPRTES 
(74) 
*OH-CATH30  
(King cobra) 
KFFKKLKNSVKKRAKKFF
KKPRVIGVSIPF 
(75) 
*OH-CM6  
(King cobra) 
KFFKKLKKAVKKGFKKF
AKV 
(75) 
β-sheet 
structured 
peptides 
Peptides with 2 
disulphide bonds 
Protegrin-1 
(porcine leukocytes) 
RGGRLC1YC2RRRFC1VC2
VGR 
(76) 
Tachyplesin-1  
(Tachypleus gigas, crab) 
KWC1FRVC2YRGIC2YRR
C1R 
(77) 
Peptides with 3 
disulphide bonds 
human θ defensins-1 
(human tissue) 
DHYNC1VSSGGQC2LYSA
C3PIFTKIQGTC2YRGKAK
C1C3K 
(78) 
Rhesus θ defensin-1 
(Rhesus monkey) 
GFCRCLCRRGVCRCICTR (79) 
*Rhesus θ defensin-2 
(Rhesus monkey) 
GVCRCLCRRGVCRCLCRR (80) 
Extended 
peptides 
Rich in His 
Histatin-5  
(human saliva) 
DSHAKRHHGYKRKFHEK
HHSHRGY 
(81, 82) 
Rich in Trp 
Indolicidin 
 (bovine neutrophils) 
ILPWKWPWWPWRR (83, 84) 
Rich in Arg and Pro 
Bactenecin-5 
(bovine neutrophils) 
RERPPIRRPPIRPPFYPPFRP
PIRPPIFPPIRPPFRPPLRFP 
(85, 86) 
Rich in Arg and Pro 
PR-39  
(porcine neutrophils) 
RRRPRPPYLPRPRPPPFFPP
RLPPRIPPGFPPRFPPRFP 
(87) 
Rich in Phe and Pro 
Prophenin-1 
(porcine neutrophils) 
RGGRLCYCRRRFCVCVGR (88, 89) 
Rich in Arg 
*Protamine  
(Salmon sperm) 
MPRRRRSSSRPVRRRRRP
RVSRRRRRRGGRRRR 
(90) 
Loop 
structured 
peptides 
  
Lactoferricin  
(cow and human milk) 
FKC1RRWQWRMKKLGAP
SITC1VRRAF 
(91) 
Bactenecin  
(bovine neutrophils) 
RLCRIVVIRVCR (92) 
Nisin A  
(Lactococcus lactis) 
ITSISLCTPGCKTGALMGC
NMKTATCHCSIVHSK 
(93) 
        
 
     * Analyzed in this study 
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β-sheet structured AMPs. Another extensively studied group of AMPs are β-sheet 
structured AMPs. These cyclic peptides are connected by disulfide bonds which 
contribute to their antimicrobial activity (94). While they exist as β-sheets, their 
conformations are stabilized upon interaction with phospholipids. It has been proposed 
that these AMPs exert their activities by disrupting the phospholipid membranes or by 
forming channels (95, 96). 
Extended AMPs. The class of extended AMPs is characterized by their unusual amino 
acid composition in which there is an abundance of one or more amino acids in the 
peptide sequence. The nature of the abundant amino acid(s) will ultimately determine the 
mechanism in which the AMP will behave. For example, indolicidin, which is abundant 
in tryptophan residues, is proposed to have a turn conformation to increase activity 
toward the membrane (83) as well as permeabilize the outer membrane to form channels 
(84, 97). Meanwhile, the role of the multiple tryptophan residues remains undetermined. 
Loop structured AMPs. The proline-arginine-rich loop structured AMPs require adoption 
to a polyproline helical type-II structure (98, 99) due to the inability to form amphipathic 
conformations because of the excessive proline residues.These looped peptides gather 
and form tubular structures that increase the permeability of the membrane. This class of 
AMPs is thought to be the most promising to be developed into antimicrobial 
therapeutics due to the short peptide length and ease of synthesis.  
Therapeutic application of antimicrobial peptides 
Salmonella and serotypes of E. coli are Gram-negative enteric bacterial pathogens, 
responsible for a variety of infectious diseases. In the United States, Salmonella was 
estimated to have an incidence of about 14 cases per 100,000 people, which roughly 
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equates to 30,000 cases in 2006 (100). Moreover, in 2011, Salmonella was implicated in 
over 1 million cases of infection – 20,000 of which resulted in hospitalization, while 378 
were fatal (100).  These data made Salmonella the cause of ~30% of all foodborne 
illness-related deaths in the U.S. last year (100). Similarly, in 2003, E. coli infections 
were estimated to have caused more than 2,000 hospitalizations in the U.S. resulting in 
about 60 fatalities (101). In that year, pathogenic E. coli infections were estimated to cost 
$405 million leaving a large impact and burden on the health care system (102).  
Although there has been a decline in the number of reported cases over the decades due 
to various treatment regimens, including multiple generations of antibiotics, lack of or 
improper treatment continues to lead to millions of deaths worldwide each year (103). To 
make matters worse, the past few decades have seen the emergence of multidrug-resistant 
(MDR) bacteria, which has led to increased disease and fatality incidence (104-106). As 
the dangers of MDR bacteria begin to surface due to the rising prevalence of these 
strains, the fight to prevent and treat these infections becomes increasingly difficult. With 
millions of cases leading to thousands of hospitalizations and excessive costs in the U.S. 
each year, it is vital to develop alternative treatments to combat these quickly evolving 
pathogens. 
Antimicrobial peptides (AMPs) can be considered a promising next-generation 
pharmaceutical therapy to combat bacterial pathogens because they exert their effects in 
broad and different ways than conventional antibiotics. Due to their amphipathic nature, 
in which they contain an abundance of hydrophobic residues (~50%), they are thought to 
interact with bacterial membranes without specific receptors which would reduce the 
possibility of spontaneous resistance (reviewed in (68)). This is unlike antibiotics which 
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act on proteins generally involved in specific cellular processes and are commonly 
modified in drug resistant strains (reviewed in (68)). Additionally, AMPs can broadly 
exert their bactericidal activity against Gram-positive and/or Gram-negative bacteria, as 
well as fungi, parasites, protozoa, viruses, and cancer cells (65, 107). They are currently 
used in the food industry; for example, nisin and pediocin PA-1, bacteriocins produced 
from lactic acid bacteria, are commonly used due to their potent activity against 
foodborne pathogens and fungal microbes that can spoil food (108). While AMPs present 
a promising alternative to conventional antibiotics, the sensitivity of their nature presents 
challenges, including limit in drug delivery due to the inability to be taken orally. While 
this issue is somewhat minor (topical and injection delivery methods have provided 
solutions), the major challenge of relative high production costs remains unresolved 
(reviewed in (68)). Therefore, it will be necessary to design novel AMPs that can exert 
their effects broadly and potently, while being simple in structure to allow for high 
production at minimum costs (68). The design of such peptides is limited, however, due 
to the incomplete understanding of the mechanisms in which AMPs exert their activities 
and how bacteria evade these host-secreted peptides. 
Physiological mechanisms of action of antimicrobial peptides 
It is no surprise that the diversity of the characterized AMPs would yield diversity in their 
mechanisms of action. As such, several physiological models regarding the bactericidal 
activity of AMPs have been proposed (summarized in (109)).  
Outer membrane disruption. One commonality amongst several AMPs characterized is 
their ability to disrupt the outer membrane. Several models of the disruption have been 
discussed, such as neutralization of membrane charge in a small area or binding to the 
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negatively charged lipopolysaccharide (LPS). Such disruptions allow the AMP to form 
voltage-dependent ion channels or transmembrane pores to permeabilize or penetrate the 
membrane to exert their activities (66). In fact, in E. coli β-sheet defensins and the 
amphipathic melittin have been shown to permeabilize the phospholipid membrane and 
generate blebs (110), while α-helix structured AMPs such as cecropin penetrate the 
membrane to form voltage-dependent ion channels (111, 112). Others, such as magainin 
2, have been shown to penetrate the membrane which results in the loss of intracellular 
metabolites ultimately disrupting energy-transducing processes which lead to cell lysis 
(113, 114). 
Intracellular targets of AMPs. It was determined that the permeabilization of the outer 
membrane is not the primary cause of bacterial death when challenged with AMPs (66, 
115). For pore-forming AMPs, it can be stipulated disruption of the proton motive force 
is the ultimate cause of cell death. However, not all AMPs form pores in the membrane 
suggesting they may target other components of the cell. Along these lines, proline-rich 
Buforin II does not damage the bacterial membrane; instead, it accumulates in the 
cytoplasm to carry out its bactericidal activity against nucleic acids (116). Other AMPs 
have also been shown to traverse the outer and inner membranes to inhibit synthesis of 
biologically important molecules and cellular pathways (117). For example, the arginine-
rich peptide indolicin completely inhibits nucleic acid synthesis. Meanwhile, the α-helix 
structured peptides, pleurocidin and dermaseptin; proline-rich peptide, PR-39; and α-
defensin human neutrophil peptides, HNP-1 and HNP-2, interfere with nucleic acid and 
protein synthesis. It is difficult to identify a specific target or mechanism due to the 
breadth of the cellular pathways inhibited by AMPs. It can be posited that an 
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accumulation of hydroxyl radicals or other reactive oxygen species can be the cause of 
the mass inhibition of cellular pathways (118). 
Commonality amongst mechanisms. Regardless of the mechanism of action, one common 
feature amongst the models is the initial interaction between the positively charged AMP 
and the negatively charged membrane. A hallmark of AMPs is the specificity to 
microbial cells while being relatively ineffective against eukaryotic membranes. This is 
due to the difference in membrane composition (77) (119); bacteria have an abundance of 
negatively charged phospholipids that comprise the outer and inner membranes of Gram-
negative bacteria and the cytoplasmic membrane of Gram-positive bacteria. For example, 
the E. coli membrane contains approximately 5% cardiolipin and 20-25% 
phosphatidylglycerol (120).  Additionally, the presence of the negatively charged LPS on 
the outer membranes of Gram-negative bacteria or the teichoic acids that are present in 
the cell walls of Gram-positive bacteria makes the cell envelope an attractive target for 
positively charged AMPs. On the other hand, the membrane composition of normal 
mammalian cells is remarkably different as it is mostly composed of zwitterionic 
phospholipids phosphatidylcholine and sphingomyelin (121, 122), making the 
membranes inappropriate targets for AMPs. Thus, the cell envelope, specifically the cell 
membranes and respective cell wall components, play a vital role in the activity of AMPs. 
Physiological characteristics that affect the bactericidal activity of antimicrobial 
peptides 
Role of LPS in resistance to AMPs. Studies with Salmonella and magainin 2 have been 
carried out to ascertain the role of LPS in AMP-mediated killing. Increased loss of 
resistance was found in LPS mutants in which the length of the LPS moiety was 
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sequentially reduced (123) suggesting that LPS can have a protective role and prevent 
AMPs from reaching the membrane. Further, overall charge and abundance of LPS 
molecules on the cell envelope were found to be contributing factors in determining the 
effect of LPS on AMP activity. This suggests that LPS can serve as a protector by 
inhibiting the AMP from reaching the outer membrane. 
Role of phospholipid membranes in resistance to AMPs. The composition of the 
phospholipid bilayer (discussed above) can influence the efficacy with which AMPs exert 
their activities. Specifically, the net charge, fluidity, and curvature strain of the 
membranes are major contributing factors. Charge: Cationic AMPs have been shown to 
have greater electrostatic interactions with phospholipid membranes containing the 
negatively charged phosphatidylglycerol (114). Fluidity: In general, bilayers with 
increased fluidity have been shown to have less resistance to AMPs (124) because 
cholesterol, which reduces bilayer fluidity, was able to reduce AMP activity (125) 
Curvature strain: Phospholipids possessing small hydrophilic head groups such as 
phosphatidylethanolamine cause a concave bending of the membrane monolayer 
resulting in negative curvature and inhibition of magainin-induced pore formation (114). 
Addition of palmitoyllysophosphatidylcholine, which reduces the negative curvature, 
facilitated the magainin-induced permeabilization (114). Further, it can be postulated that 
AMPs target cellular locations with the largest cell wall curvature, i.e., the poles and 
septum, which is primarily composed of the acidic phospholipid, cardiolipin (126, 127). 
This is supported by the observation that the human derived cationic AMP, LL-37, 
preferentially targets the septa of dividing cells (128). 
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Genetic mechanisms of action to evade bactericidal effects of antimicrobial peptides 
Bacterial development of a complete resistance to AMPs is thought to be impossible (66); 
however, enteric bacteria have developed mechanisms to offset the bactericidal activities 
of AMPs. Many loci representing several independent pathways have been implicated in 
resistance to various AMPs (summarized in Table 2); however, the Salmonella 
typhimurium PhoP/PhoQ two-component system has been demonstrated as a global 
regulator of AMP resistance.  
PhoP/PhoQ-mediated resistance to AMPs. Deletion of Salmonella phoP is pleiotropic as 
it has many phenotypes associated with it, including increased susceptibility to AMPs 
due to the lack of various PhoP-dependent genes that mediate resistance (Table 2). There 
are multiple PhoP-mediated strategies reported to confer resistance to AMPs (discussed 
in (7)) that make the PhoP/Q system a global contributor in resistance to AMPs, 
including (i) modification of lipopolysaccharide (LPS) and (ii) synthesis of 
extracytoplasmic proteases that degrade the AMPs. Modification of the outer membrane: 
PhoP-dependent modification of the outer membrane is a mechanism Salmonella employ 
to evade AMP killing. Resistance is facilitated by modification of the lipid A moiety of 
LPS to reduce electrostatic interactions between the positively charged AMPs and the 
negatively charged outer membrane (129-131) as well as alter the membrane fluidity to 
reduce the effectiveness of the AMP to peremabilize the membrane (discussed above; 
(132)). Specifically, the outer membrane protein, PagP, modifies LPS via addition of 
palmitate to lipid A (133) to increase Salmonella resistance to -helical AMPs (115). 
Also regulated by the PmrA/PmrB TCS, ugd and pmrF encode enzymes required for the 
synthesis and incorporation of 4-aminoarabinose into LPS. As such, resistance to  
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Table 2. Genes previously determined to be required for AMP resistance. 
Peptide(s) Bacteria Gene(s) 
Reg. 
System(s) 
Ref 
Protamine, Magainin 2, Melittin 
E. coli 
Salmonella 
amiA 
amiC 
CpxR/A (15) 
Lactoferricin B E. coli degP CpxR/A (134) 
Polymyxin B, Protamine, Protegrin-1 Salmonella mig-14 
PhoP/Q 
SlyA 
(135) 
Protamine E. coli ompT  (136) 
Polymyxin, Azurocidin, BPI, 
Protamine, Polylysine 
Salmonella pagB 
PhoP/Q 
PmrA/B 
(137) 
C18G Salmonella pagP PhoP/Q (115) 
Protamine, C18G Salmonella pgtE 
PhoP/Q 
SlyA 
(138) 
Cecropin P1, Magainin 2, Mastoparan,  
Melittin, Defensin NP-1,  
 Polymyxin B, Protamine 
E. coli 
Salmonella 
phoP 
phoQ 
PhoP/Q (139-142) 
Polymyxin, Polylysine, Protamine, 
CAP37, CAP57 
Salmonella 
pmrA 
pmrB 
PhoP/Q 
PmrA/B 
(137, 143-146) 
Polymyxin B Salmonella 
pmrE 
pmrF 
PmrA/B (129) 
Polymyxin B Salmonella rcsC RcsB/C (147) 
Crp4, P2 (BPI) Salmonella rpoE E (148) 
Protamine Salmonella sapABCDF  (149) 
Protamine Salmonella 
sapG 
sapJ 
 (150) 
Magainin 2, Polymyxin B Salmonella slyA 
PhoP/Q 
SlyA 
(140, 151) 
Polymyxin B Salmonella somA PhoP/Q (147) 
Protamine, Magainin 2, Melittin 
E. coli 
Salmonella 
tatA 
tatB 
tatC 
 (15) 
Magainin 2, Polymyxin B Salmonella ugtL 
PhoP/Q 
SlyA 
(140) 
Polymyxin B Salmonella virK 
PhoP/Q 
SlyA 
(147) 
Protamine, Melittin, Polymyxin B, 
Human Defensins 
Salmonella yejABEF  (152) 
Protamine, Magainin 2, Melittin Salmonella yqjA 
CpxR/A 
PhoP/Q 
(140) 
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polymyxin B is also facilitated by LPS modification to lipid A (130, 153).   
Protease-mediated degradation of AMPs: Protease-specific degradation of AMPs is 
another strategy employed to evade AMP activity. PhoP-dependent pgtE encodes an 
outer membrane protease that, when expressed at high levels, will contribute to resistance 
to the C18G AMP by cleaving C18G (138). Similar protease-facilitated cleavage of 
AMPs is observed by the OmpT protease in E. coli (136). 
PhoP-independent resistance to AMPs. While PhoP/Q has been demonstrated as a global 
regulator in bacterial resistance to AMPs, it should be noted that several PhoP-
independent loci have been demonstrated to contribute to bacterial resistance to AMPs. 
The Sap transporter: Deletion of members of the sapABCDF operon, which encodes a 
periplasmic oligopeptide-binding protein and its inner membrane transporter, rendered 
Salmonella cells susceptible to the model AMP, protamine (150). It is thought that this 
system mediates resistance by transporting protamine from the periplasm to the 
cytoplasm where it is degraded by cytoplasmic proteases. The Yej Transporter: Deletion 
of yefF, which encodes the ATPase component of the  ATP-binding cassette transporter 
encoded by the yejABEF operon, rendered Salmonella cells susceptible to multiple 
classes of AMPs, represented by protamine, melittin, polymyxin B, and human β-
defensins HBD-1 and HBD-2 (152). Additionally, ΔyejF had reduced virulence when 
inoculated intragastrically (152) suggesting that the YefABEF transporter contributes to 
Salmonella virulence by facilitating resistance to AMPs. 
Rationale of the dissertation studies 
Over 1,000 AMPs of various natures have been characterized (64) and shown to exert 
their effects in ways different from modern day antibiotics, making them a promising 
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next-generation pharmaceutical therapy to combat bacterial pathogens.  Therefore, it is 
important to understand the molecular mechanisms, both genetic and physiological, 
behind bacterial resistance to AMPs to overcome the challenges faced with the 
development of new drug therapies and vaccines. Research regarding the genetic 
circuitries required for bacterial resistance to AMPs has been challenging due to the 
sensitivity of AMPs to various laboratory conditions (salts, buffers, media, etc.) and a 
lack of adequate and efficient genetic tools. Although there have been a few mechanisms 
proposed to mediate bacterial resistance to AMPs (discussed above), including (i) lipidA 
modification of the LPS (115, 129), (ii) cleavage of AMPs by outer membrane proteases 
(136, 138) and (iii) membrane bilayer rearrangements to inhibit lipid-peptide pore 
formation (113, 114), the lack of genetic determinants limits the identification of 
additional physiological mechanisms. While the PhoP/Q system has been demonstrated 
as a major contributor in resistance to AMPs, I believe that additional PhoP/Q-
independent mechanisms must exist to further contribute to resistance. 
 In this study, data and analysis are presented from a large scale, systematic screen in 
which I used the entire Keio collection (154) of ~4,000 E. coli in-frame, single gene 
deletion mutants to identify loci required for resistance to AMPs. The identification of 
these loci served as a tool for me to identify novel genetic circuitries required for 
resistance and likely other physiologically significant processes; and thus, has provided a 
basis for the work described in this dissertation study. 
In Chapter 1, I discuss the results of the systematic analysis in which E. coli mutants were 
challenged against physiologically significant peptides representing -helix and -sheet 
classes of AMPs, as well as a model AMP. Notably, this chapter identifies the 
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significance of the Tat system in bacterial resistance to AMPs which is further 
characterized in Chapter 2. I also provide evidence of the importance of enterobacterial 
common antigen biosynthesis in resistance to antimicrobial substances. Cumulatively, the 
analysis of this chapter served as a foundation for the work described in Chapters 2-4. 
In Chapter 2, I build on a hypothesis generated from data in Chapter 1 in which I identify 
Tat-dependent substrates required for bacterial resistance to protamine. Two of these 
substrates, AmiA and AmiC, are further characterized in Chapter 3. 
Chapter 3 discusses the biochemical and genetic aspects of this study in which the 
CpxR/CpxA two-component system is found to be a major regulator for several loci 
required for resistance to AMPs. Specifically, I determined that the amiA, amiC, and 
marRAB loci, as well as the rfe-rff gene cluster are regulated by CpxR. 
Chapter 4 wraps up the study by collectively describing a new regulatory system, 
CpxR/A, as a major contributor to bacterial resistance to AMPs. Multiple CpxR/A-
dependent loci, either characterized previously or in this study, were found to contribute 
to resistance. The identification of this system proves the original hypothesis of this study 
in which additional PhoP-independent systems are required for bacterial resistance to 
AMPs. 
Disclaimer. This project was initially carried out using a collection of Salmonella 
mutants to identify genes required for resistance to AMPs. However, the collection was 
never completed by collaborating laboratories and as such, never received in its entirety. 
Thus, to continue the project, the Keio collection of Escherichia coli mutants was used 
and represents a significant proportion of the strains discussed in this work.  
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MATERIALS AND METHODS 
Bacterial strains and growth conditions 
All bacterial strains used in this study are provided in Appendix A. Escherichia coli 
strains were obtained or derived from mutant strains in the Keio Collection (154) or 
derived from the wild-type strain BW25113 using the one-step gene deletion method 
(155) with primers listed in Appendix C. All Salmonella enterica serovar Typhimurium 
strains were derived from the wild-type strain using the one-step gene deletion method 
(155). Bacteria were grown at 37°C in Luria-Bertani broth (LB). When necessary, 
antibiotics were added at final concentrations of 50 g ml-1 for ampicillin, 20 g ml-1 for 
chloramphenicol, or 50 g ml-1 for kanamycin. E. coli DH5 was used as host for the 
preparation of plasmid DNA. E. coli BL21-Gold (Stratagene, Inc.) was used for protein 
expression.  
Construction of strains with chromosomal mutations harboring lac fusions 
Strains harboring deletions constructed using the one-step gene deletion method (155) 
were used to construct chromosomal lac fusions.The kanamycin- or chloramphenicol-
resistant cassette was removed using plasmid pCP20 (155) and the appropriate lac 
transcriptional fusion plasmid pCE36 or pCE37 (156) was integrated into the FLP 
recombination target sequence in the deleted locus. 
Plasmid construction 
All plasmids used in this study are described in Appendix B. Primers used to generate 
DNA fragments cloned into each plasmid are listed in Appendix C. 
Plasmid pUHE-nlpE was constructed by cloning the nlpE gene fragment (synthesized 
using 14028s or BW25113 chromosomal DNA and primers 1421 and 1422) into the  
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HindIII site of pUHE21-2lacI
q
 (157).  
Plasmid pUHE-yaeJ was constructed by cloning the yaeJ gene fragment (synthesized 
using 14028s chromosomal DNA and primers 1413 and 1414) into the HindIII site of 
pUHE21-2lacI
q
 (157). 
Plasmid pUHE-amiA was constructed by cloning the amiA gene fragment (synthesized 
using 14028s chromosomal DNA and primers 1327 and 1328) into the HindIII site of 
pUHE21-2lacI
q
 (157). 
Plasmid pUHE-amiC was constructed by cloning the amiC gene fragment (synthesized 
using 14028s chromosomal DNA and primers 1402 and 1403) into the HindIII site of 
pUHE21-2lacI
q
 (157). 
Plasmid pBAD-tatC was constructed by cloning the tatC gene (synthesized using 14028s 
chromosomal DNA and primers tatC-forward and tatC-reverse) into pBAD TOPO 
(Invitrogen). 
Plasmid pYS2135 was constructed by cloning the cpxR coding region (synthesized using 
14028s chromosomal DNA and primers 1512 and 1513) into into the NdeI and SalI site 
of pET28a (Novagen). 
Plasmid pYS1734 was constructed by cloning 570 bp of the marR promoter region 
(synthesized using BW25113 chromosomal DNA and primers 1731 and 1734) into the 
SalI and XhoI site of pYS1000 (158). 
Plasmid pYS1736 was constructed by cloning 120 bp of the marR promoter region 
(synthesized using BW25113 chromosomal DNA and primers 1731 and 1736) into the 
SalI and XhoI site of pYS1000 (158). 
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Selection for genes required for resistance to -defensin peptide 
The Keio collection of E. coli mutants, containing nearly 4,000 single mutant strains 
(154) was used to screen for genes required for resistance to the -defensin peptide, 
RTD-2 (79). Strains were cultured overnight, re-inoculated (1:100) in LB broth, and 
grown for 4 h at 37°C.  Cultures were diluted in a challenge medium (10 mM PIPES, 
0.5% LB) and approximately 10
5 
cells were challenged in a 96 well microtiter plate with 
1.5 g mL-1 peptide in the challenge medium for 2 hours in 37°C. Samples were then 
diluted (1:10) in LB broth and spotted onto LB agar plates for overnight growth at 37°C. 
Selection for genes required for resistance to -helix structured peptides  
The Keio collection (154) was used to screen for genes required for resistance to the -
helix structured peptides, OH-CATH30 and OH-CM6 (75). Strains were cultured 
overnight, re-inoculated (1:100) in LB broth, and grown for 4 h at 37°C.  Cultures were 
diluted in a challenge medium (10 mM PIPES, 0.5% LB) and approximately 10
5 
cells 
were challenged in a 96 well microtiter plate with 2 - 4 g mL-1 peptide in the challenge 
medium for 2 hours in 37°C. Samples were then diluted (1:10) in LB broth and spotted 
onto LB agar plates for overnight growth at 37°C. 
Selection for genes required for resistance to protamine  
The Keio collection (154) was used to screen for genes required for resistance to 
protamine (90). Strains were cultured overnight, re-inoculated (1:100) in LB broth, and 
grown for 4 h at 37°C.  Strains were diluted and approximately 10
2 
- 10
3
 cells were 
dropped onto LB agar plates containing varying concentrations (0.6 - 1.2 mg mL
-1
) of 
protamine sulfate (MP Biomedicals) and incubated overnight at 37°C to screen for 
sensitivity.  
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Vancomycin killing Assay 
Salmonella and E. coli survival after a vancomycin challenge was determined as follows. 
Overnight cultures were inoculated 1:5 in fresh LB broth. An appropriate inducer (0.25 
mM IPTG or 10 mM L-arabinose) was added when necessary. Strains were shaken for 4 
h at 37°C to allow for induction. Cells were diluted to ∼105 bacteria mL-1 and added to 
microtiter wells containing 0 and 0.5 mg mL
-1
 (final concentration) vancomycin (Sigma). 
Strains were challenged overnight with aeration at 37°C, and survival was determined by 
measuring the optical density. Survival percentage was calculated as described previously 
(i.e. A600 nm of culture with vancomycin/A600 nm of culture without vancomycin)×100 (53). 
SDS killing Assay 
Salmonella and E. coli survival after a sodium dodecyl sulfate (SDS) challenge was 
determined as follows. Overnight cultures were inoculated 1:5 in fresh LB broth and 
shaken for 4 h at 37°C. Cells were diluted to ∼105 bacteria mL-1 and added to microtiter 
wells containing 0, 0.01, 0.02 and 0.04 % (final concentration) SDS. Strains were 
challenged overnight with aeration at 37°C, and survival was determined by measuring 
the optical density. Survival percentage was calculated as described previously (i.e. A600 
nm of culture with SDS/A600 nm of cultures without SDS) × 100 (53). 
Deoxycholate killing assay 
Strains were cultured overnight, re-inoculated (1:100) in LB broth, and grown for 4 h at 
37°C.  Strains were diluted and approximately 10
2 
- 10
3
 cells were dropped onto LB agar 
plates containing 0 and 1% deoxycholate and incubated overnight growth at 37°C to 
screen for sensitivity.  
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Screening for a regulator that upregulates amiA and amiC transcription 
Chromosomal DNA prepared from wild-type strain 14028s was digested with Sau3AI (1 
unit; New England Biolabs) for 15, 30, or 45 min. The digested DNA was separated on 
0.8% agarose gel, and 2–5-kb fragments were recovered and ligated to BamHI-digested 
pUC19 plasmid DNA. The ligation mixture was transformed into E. coli DH5α selecting 
for ampicillin-resistant transformants. Plasmid DNA was isolated from a pool of about 
20,000 transformants (∼95% of which carried an inserted chromosomal fragment) and 
introduced into strains, YS13637 and YS13640, which harbored a chromosomal lac 
transcriptional fusion at the amiA and amiC loci, respectively. Ampicillin-resistant 
transformants were selected on LB ampicillin agar plates containing X-Gal (40 μg mL-1). 
Plasmid DNA was purified from those colonies that were darker blue than others and 
reintroduced into YS13637 and YS13640 by electroporation. The resulting strains were 
used to measure β-galactosidase activity and to compare with those that received a 
control plasmid pUC19. To determine the inserted fragments, the plasmids were 
sequenced using primers 232 and 233. 
-galactosidase assay 
-galactosidase assays were carried out in triplicate (159) and the activity (Miller Unit) 
was determined using a VERSAmax plate reader (Molecular Device). Data correspond to 
three independent assays conducted in duplicate, and all values are mean ± standard 
deviation.  
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) 
Bacterial cells were grown for 8 h in LB medium. Total RNA was isolated from bacterial 
culture using TRIzol LS reagent (Invitrogen) according to the manufacturer's instructions. 
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RNA concentration was determined by spectrophotometry at 260 nm and quality 
determined by agarose gel electrophoresis. cDNA was synthesized using murine 
leukemia virus reverse transcriptase and random primers (BioLabs). DNA was amplified 
with primers indicated in the text and resolved on an agarose gel.  
Purification of His6-CpxR protein 
The His6-CpxR protein was purified from pYS2135 expressed in E. coli BL21-Gold with 
His-Select Nickel Affinity Gel (Sigma) according to the manufacturer’s instructions. 
After purification, the fractions containing His6-CpxR protein were desalted and 
concentrated using Amicon Ultra centrifugal filter (Millipore). 
Primer Extension 
The primer extension assay was performed using primers 1472 for amiA and 1482 
for amiC as described previously (160). Total RNA was isolated from bacterial cells 
grown in 5 ml of LB medium containing IPTG (0.25 mM) to A600 nm 0.6 with RNAzol 
(Molecular Research Center) by following the manufacturer's instructions. Samples were 
analyzed by 6% denaturing polyacrylamide electrophoresis by comparison with DNA 
sequences amplified from Salmonella chromosome with primers 
32
P-1472 and 1567 
for amiA, or 
32
P-1482 and 1484 for amiC and generated using Maxam and Gilbert A + G 
reactions. 
Electrophoretic Mobility Shift Assay (EMSA) 
Primers were labeled using T4 polynucleotide kinase (New England Biolabs) and [γ-32P] 
ATP (PerkinElmer Life Sciences). Approximately 10 nmol of 
32
P-labeled DNA 
fragments described in the text were incubated at room temperature for 30 min with 
increasing amounts of His6-CpxR protein in 20 μl of an EMSA buffer consisting of 10 
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mM Tris-HCl (pH 7.5), 1 mM EDTA, 5 mM DTT, 10 mMNaCl, 1 mM MgCl2, and 5% 
glycerol. After the addition of the DNA dye solution (40% glycerol, 0.05% bromphenol 
blue, 0.05% xylene cyanol), the mixture was directly subjected to 4% polyacrylamide 
electrophoresis. Signals were detected by autoradiography. 
DNase I footprinting assay 
DNase I footprinting assays were carried out using DNA fragments amplified by PCR 
using BW25113 or 14028s chromosomal DNA as template. Before PCR, one primer for 
each set was labeled with T4 polynucleotide kinase (New England Biolabs) and [-32P] 
ATP (Perkin Elmer) to yield a labeled coding strand and a labeled non-coding strand. 
Approximately 25 pmol of labeled DNA and increasing amounts of His6-CpxR protein 
were mixed in a 100 l reaction containing 2 mM HEPES pH8.0, 10 mM KCl, 20 µM 
EDTA, 0.5 mg ml
-1
 BSA, 20 µg ml
-1
 poly(dI-dC), 2% glycerol (161). The reaction 
mixture was incubated at room temperature for 20 min. Then, a DNaseI solution (10 mM 
CaCl2, 10 mM MgCl2, and 0.01 units of DNase I (Fermentas)) was added and the mixture 
was incubated at room temperature for 3 min. The DNase I digestion was stopped by 
phenol treatment and the DNA was precipitated. Samples were analyzed by 6% 
polyacrylamide electrophoresis by comparison with a DNA sequence ladder generated 
with the same primers using a Maxam and Gilbert A+G reaction. The site-directed 
mutagenesis of the amiA and amiC DNA fragments was performed by following a two-
step PCR method described previously (162). The first step used the mutagenic primers 
and the reverse universal primer 1472 or 1482 flanking the 3′ end of the amiA or amiC 
promoter region. The mutagenic primers for CpxR box 1 mutation of amiA was 1595; 
while the CpxR box mutation of amiC was 1598. The second step used the product of the 
32 
first PCR as a primer and the forward universal primer 1567 or 1484 to yield the whole 
promoter region with the desired mutation. DNase I footprinting assay was then carried 
out as described above. 
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CHAPTER 1 
IDENTIFICATION OF GENETIC LOCI REQUIRED FOR BACTERIAL 
RESISTANCE TO ANTIMICROBIAL PEPTIDES   
Introduction 
Antimicrobial peptides (AMPs) are products of the host innate immune system serving as 
a first line of defense for protection against microbial invaders (67). They exert their 
potent bactericidal activities against multiple pathogens, making them a promising 
alternative to conventional antimicrobial treatments. While there have been some reports 
describing the genetic basis for AMP resistance, research in the area has been a challenge 
due to the inability and unfeasibility to conduct large scale screens with sensitive, 
physiologically significant AMPs, as well as a lack of adequate genetic tools. In fact, 
previous screening efforts to identify genetic determinants required for resistance 
employed transposon-mediated mutant libraries in which transposons were randomly 
inserted into the chromosome (141). Otherwise, plasmid-mediated screens were used in 
which a plasmid library, constructed by randomly cleaving the chromosome and inserting 
fragments into an appropriate vector, was introduced into a phoP background to identify 
DNA fragments that could rescue the AMP-susceptible phenotype (140). While feasible, 
both strategies were, however, limited by the likelihood of an incomplete library due to 
the possibility of uneven distribution of transposon insertion across the chromosome or 
insufficient DNA fragments inserted into the vector.  As such, research in this area has 
remained limited. In fact, only a single two-component regulatory system, PhoP/PhoQ, 
had been implicated as a global regulator for bacterial resistance to AMPs, as well as the 
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PmrA/PmrB two-component system which can be activated by PhoP/PhoQ (139, 163, 
164). 
The availability of the Keio collection (154) containing ~4,000 defined Escherichia coli 
single gene deletion mutants provided an opportunity for a large scale, systematic screen. 
As such, this collection has successfully been used as a tool to identify loci required for 
resistance to various antibiotics (165-167). Therefore, the Keio collection was used in this 
study to individually challenge mutant strains against four AMPs representing three 
classes (summarized in Table 3). The first, protamine, is a 32-amino acid AMP isolated 
from salmon sperm (90).  Although it is not physiologically significant (i.e., its natural 
function is not to protect its host from invading pathogens), it is commonly used as a 
model AMP because it has been shown to kill Salmonella cells harboring mutations of 
virulence determinants, such as phoP (164). In lieu of peptides isolated from biologically 
significant organisms, such as defensins and magainins, protamine is commonly used 
amongst the scientific community because it allows for large-scale use due in part to its 
availability and relatively low cost, as well as its integrity under harsh laboratory 
conditions. It has been argued that analyses to understand bacterial resistance to AMPs 
using an AMP that is not naturally occurring are insignificant; therefore, it was necessary 
to analyze naturally occurring, and thus physiologically significant peptides. The second 
peptide used in the screen, RTD-2, is a -defensin isolated from Rhesus monkey, 
representing the -sheet class of AMPs (79, 80). The high potency and insensitivity to 
physiological NaCl (79) compared to other characterized AMPs make RTD-2 a 
physiologically significant peptide and thus relevant for this study. The last class of  
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Table 3. Description of AMPs analyzed in this study.  
AMP Name AMP Type AMP Class AMP Sequence Ref 
Protamine Arg-rich extended 
MPRRRRSSSRPVRRRRRPRVS
RRRRRRGGRRRR 
(90) 
RTD-2 θ-defensin β-sheet GVCRCLCRRGVCRCLCRR 
(79) 
OH-CM6 cathelicidin α-helix KFFKKLKKAVKKGFKKFAKV 
(75) 
OH-CATH30 cathelicidin α-helix 
KFFKKLKNSVKKRAKKFFKK
PRVIGVSIPF 
(75) 
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AMPs used in the screen, -helix structured peptides, are represented by two peptides: 
OH-CATH30, a cathelicidin characterized from king cobra, and its short-form analog, 
OH-CM6 (75). The potent efficacy and low host toxicity of these peptides (75) make 
them ideal candidates for therapeutic use and physiologically significant for this study. 
Systematic screen to identify genes required for bacterial resistance to AMPs 
Method for identifying genes required for bacterial resistance to AMPs. Systematic 
screens were carried out in parallel to identify gene loci required for resistance to 3 
classes of AMPs, which allowed for identification of trends or common mechanisms 
amongst the AMPs. The premise was based on the notion that if a gene product is 
required for resistance to an AMP, then deletion of the gene should result in increased 
susceptibility to the AMP when compared to the isogenic wild-type. Nearly 4,000 E. coli 
single gene deletion mutant strains from the Keio collection (154) were challenged 
against each AMP to determine if deletion of individual loci could result in increased 
susceptibility. Challenges were carried out using standard laboratory conditions, i.e., cells 
cultured in LB broth with aeration at 37°C, spotted onto LB agar plates and incubated at 
37°C overnight. These enriched conditions were used as opposed to defined media to 
avoid inadvertent bias towards a specific group of loci (e.g., PhoP-activating conditions 
in low Mg
2+
 conditions). Overall, the screen identified 112 mutants that were susceptible 
to at least one screened peptide (APPENDIX D): 11 mutants susceptible to RTD-2; 19 
mutants susceptible to OH-CM6; 79 mutants susceptible to OH-CATH30; and, 32 
mutants susceptible to protamine. 
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Table 4. Gene mutants susceptible to θ-defensin, RTD-2. 
Functional Group Gene Function Gene Name 
Enterobacterial 
Common Antigen 
(ECA) Synthesis 
TDP-fucosamine acetyltransferase rffC 
TDP-Fuc4NAc:lipidIIFuc4NAc transferase rffT 
DNA Repair DNA strand exchange and recombination protein recA 
Membrane Protein 
outer membrane protein A ompA 
predicted peptidase, outer membrane lipoprotein spr 
Regulator 
DNA-binding transcriptional dual regulator argR 
DNA-binding regulator in TCS with CpxA cpxR 
DNA-binding transcriptional dual regulator crp 
predicted folate-dependent regulatory protein ygfZ 
Transporter TatABCE protein translocation system subunit tatC 
Unknown Function conserved protein yajD 
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Systematic screen to identify genetic loci required for bacterial resistance to β-sheet 
structured -defensin, RTD-2. It has been argued that genetic screens using an AMP that 
is not naturally occurring are insignificant; therefore, a screen was carried out using a 
synthetic form of the naturally occurring –defensin, RTD-2, isolated from circulating 
leukocytes of the Rhesus monkey (79, 80). The synthetic form was found to be 
biochemically and functionally indistinguishable from the natural isolate; thus, it exhibits 
potent bactericidal and fungicidal activities as well as insensitivity to physiological NaCl 
compared to other physiologically significant AMPs (79). To identify genetic loci 
required for resistance to RTD-2, mutant strains of the Keio collection (154) were 
individually cultured overnight in LB broth medium in a 96-well format, re-inoculated 
(1:100) into fresh LB broth and grown with shaking at 37°C to log phase (approximately 
four hours). Approximately 10
3
 cells were challenged with RTD-2 for 2 h with shaking at 
37°C. Samples were diluted 1:10 and spotted onto LB agar plates and incubated 
overnight at 37°C. Mutant strains in which growth was inhibited, compared to wild-type, 
were selected for further analysis. The screen identified 11 sensitive mutant strains which 
represented an array of cellular functions, including enterobacterial common antigen 
biosynthesis, DNA repair, gene regulation, and protein transport (Table 4). Notably, 4 
out of the 11 loci encode a regulator (i.e., ArgR, CpxR, Crp, and YgfZ), suggesting an 
integrated regulatory approach to mediate bacterial resistance to the θ–defensin. 
Additionally, 9 of the 11 mutant strains were susceptible to at least one cathelicidin 
screened (Figure 7), suggesting a global contribution of their gene products to AMP 
resistance. 
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Systematic screen to identify genetic loci required for bacterial resistance to -helix 
cathelicidins, OH-CATH30 and OH-CM6. An additional systematic screen was 
conducted to identify genetic loci required for resistance to a naturally occurring -helix 
cathelicidin peptide, OH-CATH30, characterized from king cobra, and its short-form 
analog, OH-CM6 (75). The potent efficacy and low toxicity of these peptides make them 
suitable candidates for therapeutic use and therefore, physiologically significant for this 
study.The screen was carried out as described above using various concentrations of OH-
CATH30 and OH-CM6. The short-form AMP, OH-CM6, was expected to have less 
susceptible candidates due to the higher minimum inhibitory concentration (MIC) values 
reported compared to OH-CATH30 when used against clinical bacterial isolates (75), 
perhaps due to the loss of residues that contribute to the bactericidal effect of the AMP. 
As predicted, the screen identified 19 OH-CM6-sensitive mutant strains and 79 OH-
CATH30-sensitive mutant strains (APPENDIX D). 
Since OH-CM6 is a short-form isomer derived from OH-CATH30 (75), a significant 
overlap in the mutants susceptible to these cathelicidins was predicted. Indeed, 13 
candidates (68% of OH-CM6 candidates and 16% of OH-CATH30 candidates) were 
sensitive to both cathelicidins (Figure 7, double line) and represent diverse cellular 
functions, including cell wall/envelope biogenesis, gene regulation, ion transport, and 
DNA/RNA synthesis/repair (Table 5). Cumulatively, this provides evidence that OH-
CM6 contains a region of OH-CATH30 that allows it to exert its bactericidal activity 
because a significant overlap of OH-CM6-sensitive mutants (~68%) that was also 
sensitive to OH-CATH30 (Figure 7, double line). Conversely, these data also suggest 
that OH-CM6 lacks specific residues required for bactericidal activity because very few  
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Table 5. Gene mutants susceptible to both cathelicidins. 
Functional Group Gene Function Gene Name 
Cell Wall/ 
LPS/Fatty Acid 
Biosynthesis 
PLP-dependent alanine racemase 2 dadX 
fatty acid oxidation complex subunit alpha fadB 
TDP-fucosamine acetyltransferase  rffC 
TDP-Fuc4NAc:lipidIIFuc4NAc transferase  rffT 
DNA/RNA/ 
Protein 
Biosynthesis/ 
Degradation 
endonuclease IV  nfo 
DNA strand exchange/recombination protein recA 
ssDNA exonuclease  recJ 
50S ribosomal subunit protein L32 rpmF 
endonuclease/exonuclease/phosphatase family xthA 
Regulator 
DNA-binding transcriptional dual regulator feaR 
manno(fructo)kinase  mak 
predicted DNA-binding transcriptional regulator yijO 
Respiration  predicted iron-sulfur protein in electron transport  rsxB 
Transporter  
citrate:succinate antiporter  citT 
gluconate transporter ddpX 
hexuronate transporter exuT 
potassium translocating ATPase, subunit A kdpA 
manganese/divalent cation transporter mntH 
Unknown Function  predicted protein yehM 
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(13 of the 79 mutants, 16%) OH-CATH30-sensitive mutants were also sensitive to OH-
CM6 (Figure 7, double line). To further characterize the bactericidal actions of these 
AMPs, a concentration-dependent challenge against wild-type, BW25113, was carried 
out to determine the MIC of each AMP. In agreement with previous reports (75), OH-
CATH30 had a lower MIC of 1 µg mL
-1
 than OH-CM6 at 2 µg mL
-1
 (Figure 1). 
Systematic screen to identify genetic loci required for bacterial resistance to model AMP, 
protamine. Although protamine is not considered physiologically significant, it is 
commonly used as a model AMP because it has been shown to kill Salmonella cells 
harboring a phoP muatant (164) and allows for large-scale use due in part to its 
availability and relative low cost, as well as its integrity under harsh laboratory 
conditions. Once again, mutants of the Keio collection (154) were individually cultured 
overnight in LB broth in a 96-well format, re-inoculated (1:100) into fresh LB broth and 
grown with shaking at 37°C to log phase (approximately four hours). Samples were 
diluted 10
5
 times and spotted onto LB agar plates supplemented with no or various 
amounts of protamine and incubated overnight at 37°C. Mutant strains in which growth 
was inhibited, compared to wild-type, were selected for further analysis. A total of 32 
protamine sensitive mutant strains were identified which represented a multitude of 
cellular functions, including respiration, biosynthesis and metabolism, cell wall/envelope 
biogenesis, DNA/RNA synthesis/repair, and stress response (Table 6). Notably, 7 out of 
the 32 (~28%) protamine sensitive candidates had overlapping sensitivities to other AMP 
classes (Figure 7), suggesting that protamine can be used as a tool to ascertain the 
bactericidal effects of AMPs. Therefore, a series of assays was conducted using  
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Figure 1. Dose-dependent killing by cathelicidins.  
Dose-dependent killing of E. coli  wild-type (BW25113) cells by cathelicidins OH-CM6 
and OH-CATH30 demonstrate that OH-CATH30 has higher bactericidal activity due to 
the lower MIC, 1 µg ml
-1
, compared to the short-form isoform OH-CM6 with a MIC of 2 
µg ml
-1
. 
 
 
 
 
 
 
 
 
 
 
 
 
43 
Table 6. Gene mutants susceptible to protamine. 
Functional Group Gene Function Gene Name 
ATP Synthase 
Subunits 
F0 sector of membrane-bound ATP synthase, 
subunit a 
atpB 
F1 sector of membrane-bound ATP synthase, 
epsilon subunit 
atpC 
F1 sector of membrane-bound ATP synthase, 
gamma subunit 
atpG 
Biosynthesis/ 
Metabolism 
shikimate kinase I; catalyzes step in chorismate 
biosynthesis 
aroK 
phosphomannomutase/phosphoglucomutase cpsG 
alkaline phosphatase homolog gpmI 
Cell Wall/ LPS 
Biosynthesis 
N-acetylmuramoyl-L-alanine amidase amiC 
protease with a role in cell division envC 
heat shock protein acyltransferase lpxL 
myristoyl-acyl carrier protein-dependent 
acyltransferase; htrB suppressor  
lpxM 
ADP-L-glycero-D-manno-heptose-6-epimerase  rfaD 
Inner membrane protein of unknown function yqjA 
Enterobacterial 
Common Antigen 
(ECA) Synthesis 
 UDP-N-acetylglucosamine:undecaprenyl-
phosphate GlcNAc-1-phosphate transferase 
rfe 
TDP-fucosamine acetyltransferase rffC 
glucose-1-phosphate thymidylyltransferase rffH 
TDP-Fuc4NAc:lipidIIFuc4NAc transferase rffT 
PLP-dependent 
pyridoxine 5'-phosphate (PLP) oxidase  pdxH 
predicted enzyme that binds PLP yggS 
predicted diguanylate cyclase yhjK 
Protein Folding 
monomeric thiol disulfide oxidoreductase  dsbA 
oxidoreductase for reoxidation of DsbA  dsbB 
RNA/DNA 
Synthesis/ 
Degradation 
AMP nucleosidase  activated by PhoB amn 
ATP-dependent RNA helicase deaD 
chaperone Hsp70; DNA biosynthesis dnaK 
Stress Response 
Polynucleotide phosphorylase that protects 
against damage  
pnp 
Heat shock response chaperone; protease  degP 
SoxRS-regulated glucose-6-phosphate 
dehydrogenase 
zwf 
Transporters/ 
Pores 
cytoplasmic component of protein translocase secB 
Sec-independent protein translocase protein tatC 
outer membrane channel protein tolC 
betaine-choline-carnitine-transporter  yeaV 
putative outer membrane protein  yedS 
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protamine as the model AMP to characterize mutant strains identified in the screen and 
explore the mechanisms in which specific loci contribute to resistance. 
Characterization of select loci required for bacterial resistance to protamine 
The role of ATP production in resistance to protamine. Among the mutant strains 
susceptible to protamine were atpB, atpC, and atpG, that encode the a, ε, and γ subunits 
of the F1F0-ATP synthase, respectively. Subsequent analysis demonstrated that deletion 
of any ATP synthase-encoding loci, except atpE and atpA (not tested), resulted in 
increased susceptibility to protamine when compared to the wild-type (Figure 2, left). 
This observation generated the hypothesis that the F1F0-ATP synthase is required for E. 
coli resistance to protamine which is contrary to reports that microcin H47 requires ATP 
synthase for its activity (168) or that various cationic AMPs can bind to the ATP synthase 
and inhibit its activity (169).  
The F1 sector of the ATP synthase catalyzes the reversible processes of ATP hydrolysis 
and synthesis while the F0 sector facilitates proton transport through the inner membrane. 
Therefore, it was necessary to determine whether the synthesis/hydrolysis of ATP or the 
transport of protons through the membrane was required for resistance to protamine. 
Wild-type E. coli cells were challenged with sodium azide (a well-established inhibitor of 
the electron transport chain (ETC) which inhibits cytochrome oxidase activity), 
protamine, and both sodium azide and protamine to determine if inhibition of the ETC 
would increase susceptibility to protamine. On the contrary, bacteria were able to survive 
when challenged with protamine in the presence of sodium azide, similarly as the non-
treated cells (Figure 2, right), indicating that inhibition of ETC does not influence 
susceptibility to protamine and perhaps the generation of ATP was required. It was  
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Figure 2. Effect of ATP synthesis on resistance to protamine.  
(left) Dose-dependent killing of atp mutants show that each mutant assayed, except for 
atpE, was susceptible to protamine. (right) Succinic acid (Suc) is able to increase E. coli 
wild-type resistance to protamine (indicated with *) while sodium azide (SAz) has no 
effect, compared to the untreated cells (-).  
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therefore postulated that protamine could impede, however not abolish, cellular 
respiration at the glycolysis level. This notion is supported by the following observations: 
(i) Deletion of zwf, which encodes the glucose-6-phosphate dehydrogenase (G6PD), 
results in increased susceptibility to protamine (APPENDIX D). G6PD initiates the first 
step in the pentose phosphate pathway (PPP), an alternative pathway used instead of 
glycolysis to generate NADPH and ATP from a glucose substrate. This suggests that 
protamine can target any step in glycolysis between the first step, conversion of glucose 
to glucose-6-phosphate, and an intermediate step, conversion of fructose-6-phosphate to 
fructose 1,6-bisphosphate because the PPP shunt provides an alternative route to produce 
fructose-6-phosphate, after which, the PPP reconvenes with the glycolysis pathway 
(illustrated Figure 3). Thus, protamine should impede the traditional glycolysis pathway 
and inhibit the production of NADH and pyruvate which feed into the next step of 
respiration, the tricarboxylic acid (TCA) cycle. However, cells are able to bypass this 
putative impedance of protamine by using the PPP which serves as a shunt to utilize 
glucose and produce NADPH and ATP. Thus, in the absence of zwf, the shunt is not 
available resulting in the inability to generate ATP, as well as NADH and pyruvate. 
These byproducts are required to continue the process of cellular respiration, thus 
deletion of zwf in the presence of protamine would ultimately inhibit production of ATP 
by oxidative and substrate-level phosphorylation methods. (ii) Deletion of the F1F0-
ATPase (which abolishes the major contributor to ATP production via oxidative 
phosphorylation) increases E. coli susceptibility to protamine, presumably due to the 
inefficient production of ATP from substrate-level phosphorylation. In other words, 
deletion of the major ATP-generating system would be detrimental in the presence of  
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Figure 3. Illustration of the glycolysis and pentose phosphate pathways.  
Protamine is hypothesized to impede the glycolysis pathway between the glucose-6-
phosphate and fructose-6-phosphate intermediate steps. Cells are able to bypass this 
impedance by the pentose phosphate pathway (PPP) which provides an alternative route 
to produce fructose-6-phosphate. Thus, cellular respiration is allowed to continue through 
the tricarboxylic acid cycle (TCA) and electron transfer chain (ETC) to generate ATP. In 
the absence of the glucose-6-phosphate dehydrogenase (G6PD), encoded by zwf, cells 
become susceptible to protamine likely due to the inability to generate sufficient amounts 
of ATP. Likewise, in the absence of the F1F0-ATP synthase, encoded by atp loci, cells 
become susceptible to protamine likely due to the inability to generate sufficient amounts 
of ATP. Additionally, cells can bypass the impedance of protamine by increasing 
substrate amounts, i.e., supplementing glucose or succinic acid, to presumably increase 
the production of ATP. 
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protamine which is impeding the relatively low production of ATP via glycolysis/PPP. 
This analysis is supported by the ability of glucose supplementation to rescue the 
susceptibility of atp mutant cells to protamine (data not shown), which would presumably 
increase the production of ATP via substrate-level phosphorylation by glycolysis/PPP. 
(iii) Supplementation of formate or succinate, organic acids oxidized in the TCA cycle 
(which would increase the production of ATP via substrate-level phosphorylation), is 
able to protect bacterial cells from the oxygen consumption inhibitory effects of  human 
bactericidal/permeability-increasing protein (BPI) and increase bacterial survival in the 
presence of BPI (170) and protamine (Figure 2, right). Cumulatively, these data support 
the hypothesis in which protamine, and likely other AMPs, can impede cellular 
respiration which can ultimately lead to cell death due to the inhibition of ATP 
production (illustrated in Figure 3). 
Protamine susceptible mutants with defective outer membranes. To continue analysis of 
the loci identified in the primary screen, the susceptibilities of the mutants to various 
antibiotics and compounds were determined in order to ascertain the physiological 
condition of the mutant cells. Sodium dodecyl sulfate (SDS) and vancomycin (VAN) 
were used as tools to detect any deficiencies in the outer membrane. Deletion of envC, 
pnp, amiC, lpxL, and tatC were more susceptible to VAN than the isogenic wild-type 
(Figure 4). Similarly, deletion of envC, pnp, amiC, rfaD, and tolC were more susceptible 
to SDS than the isogenic wild-type (Figure 4). While a tolC deletion mutant is known to 
be sensitive to SDS due to the inability to pump the drug out of the cell (171), it is likely 
that the other mutant strains have defects in their outer membranes which likely increases 
permeability allowing certain compounds to enter the cell that would normally be  
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Figure 4. Gene mutant strains with increased drug sensitivity.  
Several protamine sensitive mutants are sensitive to vancomycin (VAN) and sodium 
dodecyl sulfate (SDS) inferring an increase in membrane permeability. 
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prevented by an intact outer membrane. Notably, deletion of tatC has previously been 
shown to have a defective outer membrane and thus increased susceptibility to VAN (15, 
52, 53).  
Analysis of TolC-dependent resistance to protamine. Deletion of tolC, which encodes an 
outer membrane protein involved in drug efflux, was found to result in increased 
susceptibility to protamine (APPENDIX D), suggesting a role of drug efflux systems in 
bacterial resistance to AMPs. TolC represents the outer membrane component of the 
classic AcrAB-TolC tripartite resistance-nodulation-division (RND) efflux pump in E. 
coli which facilitates the efflux of various classes of compounds out of the bacterial cell 
(discussed in (172)). It is therefore not surprising that deletion of tolC renders cells 
sensitive to AMPs since previous efforts have demonstrated the role of RND-type efflux 
pumps in bacterial resistance to AMPs in E. coli (44), Neisseria gonorrhoeae (173), 
Neisseria meningitidis (174), Campylobacter (175), Pseudomonas (176, 177), 
Yersinia (178), and Helicobacter (179). While deletion of tolC resulted in increased 
susceptibility to protamine, deletion of acrA or acrB also increased susceptibility (Figure 
5), compared to the isogenic wild-type, suggesting that an additional TolC-dependent 
efflux system could mediate bacterial resistance to protamine.  
TolC is often considered a promiscuous protein as it has many binding partners with 
other pumps, including partners belonging to other classes of efflux pumps (reviewed in 
(180)). Therefore, I sought to identify the partner(s) wtih which TolC coordinates to 
confer resistance to protamine on E. coli. Mutants of each family of drug transporter 
systems including acrA, acrB, acrD, acrE, acrF, mdtE, and mdtF (which belong to the  
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Figure 5. Protamine sensitivity assay of TolC-dependent mutants.  
Protamine sensitivity assay of mutant strains of genes encoding TolC-dependent efflux 
pumps. Deletion of acrA, acrB, emrA, and emrB render cells more susceptible (**) to 
protamine when compared to the isogenic wild-type, but not as susceptible as tolC or 
tatC controls (***). 
 
 
 
 
52 
RND family of drug transporter systems), emrA, emrB, emrK, and emrY (which belong to 
the major facilitator superfamily (MFS) of drug transporter systems), macA and macB 
(which belong to the ATP-binding cassette (ABC) family of drug transporter systems), 
and msbA, mdlA, mdlB, cydC, glnQ, and metN (which encode HlyB homologs of 34%, 
31%, 28%, 32%, 36%, and 34% sequence similarity, respectively, and belong to the ABC 
family of drug transporter systems) were individually challenged against protamine to 
determine if deletion of any gene could result in increased susceptibility to protamine 
when compared to wild-type. Indeed, deletion of acrA, acrB, emrA, and emrB resulted in 
increased susceptibility to protamine when compared to the isogenic wild-type; however, 
these mutants lower susceptibility when compared to the tolC deletion mutant (Figure 5). 
Thus, double mutants were constructed to determine if an additive effect was observed 
due to the contribution of multiple efflux systems in resistance to protamine. Double 
mutants containing either acrB or emrB along with a representative of an additional 
efflux system were constructed and challenged against protamine. As expected, deletion 
of acrB and emrB resulted in increased susceptibility compared to either individual 
mutant, however, lower susceptibility when compared to the tolC deletion mutant 
(Figure 6). Additionally, deletion of acrB along with any other efflux representative (i.e., 
acrE, emrY, glnQ, macB, mdtF, or metN), but not mdlB, resulted in increased 
susceptibility to protamine compared to any single mutant; however, none of these was as 
susceptible as the tolC mutant (Figure 6).  
A final set of mutants were constructed in which three genes (two of which were acrB 
and emrB) representing independent efflux systems were deleted in a single strain to 
determine if a cumulative effect could be observed when challenged against protamine.  
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Figure 6. Protamine sensitivity assay of TolC-dependent double mutants.  
Protamine sensitivity assay of double and triple mutant strains of genes encoding TolC-
dependent efflux pumps. An acrB emrB double deletion renders cells more susceptible to 
protamine when compared to either single deletion, however, not as susceptible as a tolC 
deletion. Deletion of a third TolC-dependent system (i.e., acrE, emrY, glnQ, macB, mdtF, 
or metN) renders triple mutant cells as sensitive to protamine as a tolC deletion, except 
for simultaneous deletion of mdlB in an acrB emrB background. 
 
WT
tolC
acrB
emrB
acrE
emrY
glnQ
macB
mdlB
mdtF
metN
acrB emrB
acrB acrE
acrB emrY
acrB glnQ
acrB macB
acrB mdlB
acrB mdtF
acrB metN
emrB acrB
emrB acrE
emrB emrY
emrB glnQ
emrB macB
emrB mdlB
emrB mdtF
emrB metN
acrB emrB acrE
acrB emrB emrY
acrB emrB glnQ
acrB emrB macB
acrB emrB mdlB
acrB emrB mdtF
acrB emrB metN
WT
tolC
[protamine]
-
***
**
*
*
*
*
*
**
***
***
***
***
***
***
***
54 
Not surprisingly, deletion of any other efflux system representative, except for mdlB, 
along with simultaneous deletion of acrB and emrB resulted in increased susceptibility to 
protamine similar to the tolC deletion (Figure 6), suggesting a global role of TolC-
dependent efflux systems in resistance to protamine. Cumulatively, these data suggest 
that the AcrA/AcrB and EmrA/EmrB systems are major efflux contributors to bacterial 
resistance to protamine, while the other systems, except for MdlB, play a modest role 
only in the absence of AcrA/B or EmrA/B. Although protamine has a relatively large 
molecular weight (~4,000 Da) compared to characterized substrates of TolC-dependent 
efflux systems, it is possible that TolC mediates the transport of protamine out of the cell 
as it is able to do for other large compounds such as haemolysin and colicins (181) and 
since AMPs have been demonstrated to be substrates of RND pumps in various bacterial 
species (44, 175-179). 
Characterization of loci required for bacterial resistance to multiple antimicrobial 
peptides 
Analysis of candidates susceptible to two or more AMPs. Surprisingly, a majority of the 
mutant strains identified in each screen were sensitive to only a single AMP. This 
suggests that (i) the gene indirectly contributes to resistance or (ii) each AMP exerts its 
bactericidal activity via different mechanisms. Overall, the screen identified 112 mutants 
that were susceptible to at least one screened peptide (APPENDIX D); 24 (~21%) of 
those mutants were found to be susceptible to two or more screened AMPs (Figure 7), 
while 13 (~12%) were susceptible to two or more classes of AMPs (Figure 7, solid line) 
suggesting a global contribution of their gene products to bacteria resistance to AMPs.  
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  Gene Name P R 6 30   Survival % Color Code 
  citT           <15%   
  dadX           15-30%   
  ddpX           30-45%   
  fadB           45-60%   
  feaR           60-75%   
  kdpA           75-90%   
  mak           >90%   
  nfo               
  recJ               
  xthA               
  yijO               
  recA               
  rffC               
  rffT               
  tatC               
  argR               
  cpxR               
  crp               
  ygfZ               
  ompA               
  rfaD               
  rfe               
  rffH               
  yggS               
Figure 7. Gene mutants found to be susceptible to 2 or more AMPs.  
Heat map illustrating gene mutants found to be susceptible to 2 or more AMPs in the 
screen.Thick line, mutants susceptible to 2 or more classes of AMPs; double line, mutants 
susceptible to both cathelicidins; dashed line, mutants susceptible to all classes of AMPs 
analyzed;  P, protamine; R, RTD-2; 6, OH-CM6; 30, OH-CATH30. 
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Moreover, only three mutants (rffC, rffT, and tatC) were susceptible to all three 
classes screened (Figure 7, dashed line); thus, these genes were further analyzed.  
Analysis of candidates susceptible to each AMP class. Deletion of tatC rendered E. coli 
cells susceptible to each class of AMPs analyzed in this study. Specifically, cells were 
susceptible to protamine, -defensin RTD-2, and cathelicidin OH-CATH30 (Figure 7). 
The tatC gene encodes a member of the twin arginine transport (Tat) system that 
transports globular proteins across the cytoplasmic membrane (45). Since tatC encodes 
an integral component of a transport system, it was hypothesized that a Tat-dependent 
substrate, and not the Tat system itself, is directly responsible for bacterial resistance to 
AMPs. Indeed, the transport of peptidoglycan amidases AmiA and AmiC to the 
periplasm was determined to be required for bacterial resistance to protamine 
(demonstrated in Chapter 2, (15)).  
Deletion of rffC and rffT rendered E. coli cells susceptible to each class of AMPs 
analyzed in this study. Specifically, the rffC mutant was susceptible to each AMP while 
the rffT mutant was susceptible to protamine, -defensin RTD-2, and cathelicidin OH-
CAM6 (Figure 7).  The rffC and rffT genes encode enzymes involved in the conversion 
of lipid II to lipid III in biosynthesis of the enterobacterial common antigen (ECA) (182). 
It was previously reported that deletion of rffA (wecE), rffT (wecF), and rffH (rmlA), 
which encode enzymes involved in the conversion of lipid II to lipid III, increased E. coli  
sensitivity to bile salts as they were unable to grow on MacConkey agar plates (55). The 
authors postulated that the accumulation of the lipid II intermediate was directly 
responsible for the increased susceptibility since deletion of rfe could rescue  
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Figure 8. Enterobacterial common antigen biosynthesis pathway. 
Illustration of the biosynthesis of the enterobacterial common antigen (adapted from 
(55)). 
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susceptibility (55). Therefore, it was hypothesized that accumulation of lipid II in the rffC 
and rffT mutants is responsible for the susceptibility to AMPs.  
Characterization of the role of the rfe-rff gene cluster in resistance to antimicrobial 
peptides 
Analysis of the rfe-rff gene cluster in resistance to AMPs. Members of the rfe-rff operon 
encode enzymes required for the biosynthesis of ECA (illustrated in Figure 8). If 
accumulation of lipid II was the cause of the increased susceptibility to AMPs, then 
deletion of other loci in the rfe-rff gene cluster should not be sensitive to AMPs as their 
gene products function elsewhere in the biosynthesis pathway. A more stringent AMP 
killing assay was conducted in which deletion of individual members of the rfe-rff gene 
cluster were challenged with the model AMP, protamine. Deletion at any locus, except 
rffG and wzzE, resulted in increased susceptibility to protamine when compared to wild-
type (Figure 9, left). This suggested the following: (i) lack of ECA, and not the 
accumulation of lipid II or any other intermediate, is responsible for the increased 
susceptibility to AMPs; and, (ii) RffG and WzzE likely have functional homologs that 
can rescue the ECA biosynthesis when these enzymes are absent. Indeed, RffG and RfbB 
(also a dTDP-glucose 4,6-dehydratase) have a 74% amino acid similarity, while WzzE 
has a 24% and 23% amino acid similarity with Cld and FepE (both also polysaccharide 
chain length modulation proteins), respectively, suggesting possible redundant or 
overlapping functions. Indeed, a rffG rfbB double mutant resulted in increased 
susceptibility to protamine, while wzzE cld and wzzE fepE exhibited no increase in 
susceptibility (Figure 9, right).  
59 
Figure 9. Susceptibility profile of mutants of the rfe-rff gene cluster.  
(left) Susceptibility profile of the rfe-rff gene cluster demonstrates that ECA is required 
for resistance to protamine and deoxycholate (DOC). (right) Double deletion of rffG and 
rfbB (rffG rfbB) makes cells susceptible to protamine. 
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Analysis of the rfe-rff gene cluster in resistance to bile salts. The observation that 
deletion of genes encoding enzymes required at any step of the ECA biosynthesis 
pathway resulted in increased susceptibility to protamine prompted a re-investigation into 
the role of ECA in resistance to bile salts. Again, it was previously determined that 
deletion of rffA (wecE), rffT (wecF), and rffH (rmlA) resulted in increased sensitivity to 
bile salt presumably due to the accumulation of the lipid II intermediate (55). However, 
another group demonstrated that deletion of Salmonella rfe (wecA) and rffC (wecD) 
caused sensitivity to the bile salt deoxycholate (57), thus dismissing the notion that lipid 
II accumulation caused sensitivity to bile salt since deletion of rfe abolishes the initiation 
of ECA biosynthesis. To support these findings, deletion of individual members of the 
rfe-rff gene cluster were challenged with deoxycholate. Deletion at any locus, except 
rffG, wzzE, and wzxE resulted in increased susceptibility to deoxycholate when compared 
to wild-type (Figure 9, left), further demonstrating that the lack of ECA, and not the 
accumulation of intermediates, is responsible for the susceptibility to bile salts.  
Deletion of ECA does not alter membrane permeability. The possibility that deletion of 
ECA could indirectly influence the susceptibility of bacteria to antimicrobials such as 
AMPs and bile salt was acknowledged. It is documented that alterations to cell wall and 
cell envelope components can increase membrane permeability (183) making cells more 
susceptible to various compounds, including sodium dodecyl sulfate (SDS) and 
vancomycin (VAN). With this in mind, survival assays were conducted with individual 
mutants of the rfe-rff gene cluster to determine if mutation would affect the sensitivity to 
SDS or vancomycin which would suggest a defect in the outer membrane. Notably, there 
was no increase in susceptibility to either compound compared to wild-type (Figure 10  
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Figure 10. SDS survival assay of rfe-rff gene cluster mutants. 
SDS survival assay of gene mutants of the rfe-rff gene cluster. 
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and data not shown), suggesting that deletion of ECA does not affect membrane 
permeability, thus inferring that it is the lack of ECA that is directly responsible for the 
increased susceptibility to AMPs and bile salts. 
The physiological role of ECA remains to be elucidated. Interestingly, rfe and rffC 
mutants were highly attenuated in a mouse model when orally inoculated, suggesting a 
protective role of ECA in virulence; and also intraceullular survival by protecting bacteria 
from bile salts (57) and AMPs (Figure 9). Therefore, understanding the means by which 
inhibition of ECA biosynthesis, or accumulation of its intermediates, confers sensitivity 
to bile salts and AMPs remain elusive. It has been postulated that the incomplete 
trisaccharide may impede the biosynthesis of the cell envelope near the site of ECA 
biosynthesis which may make the outer membrane more permeable (55). However, the 
data presented suggest otherwise due to the lack of sensitivity to SDS and vancomycin 
(Figure 10 and data not shown). Another theory suggests that protamine can act on E. 
coli similar to the way the AMP nisin acts on Gram-positive bacteria by binding to lipid 
II. It is possible that the accumulation of the ECA intermediates can increase the negative 
charge of the outer membrane resulting in increased electrostatic attraction between the 
AMP and cell membrane. While this theory may be correct, it does not explain why 
inhibition of ECA biosynthesis altogether by deletion of rfe results in increased 
susceptibility to protamine or deoxycholate (Figure 9, (57)). 
It is plausible that the susceptibility to AMPs caused by deletion of rfe is due in part to 
the absence of ECA, but also due to the absence of the LPS O-antigen since Rfe is also 
required for biosynthesis of the O-antigen (182, 184). 
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Conclusion 
Overall, the systematic screens were successful in identifying genetic loci required for 
bacterial resistance to multiple AMPs. The identification of these loci can now serve as a 
tool to identify novel genetic circuitries required for resistance and likely other 
physiologically significant processes. Interestingly, data from the screen support 
postulations that AMPs work by different mechanisms while also describing some 
overlapping features. Specifically, the identification of the enterobacterial common 
antigen as a protector for antimicrobial substances is an important finding as it further 
posits a physiological role for ECA in survival and adaptation in host environments. 
Furthermore, the identification of these loci has served as a basis for the work described 
in the upcoming chapters. 
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CHAPTER 2 
IDENTIFICATION OF TAT-DEPENDENT SUBSTRATES REQUIRED FOR 
BACTERIAL RESISTANCE TO ANTIMICROBIAL PEPTIDES 
Introduction 
The phenotypic screens carried out in Chapter 1 indicated that the tatC locus is required 
for bacterial resistance to antimicrobial peptides (AMPs) since deletion of tatC resulted in 
susceptibility to each AMP class analyzed (Figure 7). Wild-type resistance could be 
restored by expression of a plasmid (pBAD-tatC) harboring a wild-type copy of tatC and 
not a vector only (pBAD) control (Figure 11). This suggests that tatC, which encodes an 
integral component of the twin-arginine transporter (Tat) system, a Sec-independent 
system responsible for the transport of globular proteins across the inner membrane (45), 
has a global role in bacterial resistance to AMPs. The Tat system, encoded by the 
chromosomal loci tatA, tatB, and tatC, has many characterized substrates with diverse 
cellular functions, including ion acquisition, energy metabolism, cell wall biosynthesis, 
and virulence (reviewed in (47)). Since tat encodes a transporter, it was hypothesized that 
a Tat-dependent substrate(s) is directly required for bacterial resistance to AMPs. 
Identification of Tat-dependent substrates required for bacterial resistance to AMPs 
To identify the possible Tat-dependent substrate(s) required for resistance to AMPs, a 
more stringent screen was conducted using Escherichia coli mutants whose gene 
products encode one of the approximately 40 proteins that have been experimentally 
proven or hypothesized to be transported by the Tat system (Table 7). Deletion of either 
amiA or amiC resulted in an increase in protamine susceptibility when compared to wild-
type, but was not as susceptible as ∆tatC. amiA and amiC mutants were constructed in 
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Table 7. Analysis of Tat-dependent substrates in resistance to protamine. 
Ref. 
Gene 
Product 
Function 
Protamine 
(R/S) 
(45, 185)  AmiA N-acetylmuramoyl-L- alanine amidase I  susceptible  
(45, 185) AmiC N-acetylmuramoyl-L- alanine amidase  susceptible  
(185) CitE citrate lyase beta chain  resistant 
(45)(185) CueO multicopper oxidase resistant 
(45, 185) DmsA dimethyl sulfoxide reductase, A  resistant 
(45, 185) FdnG formate dehydrogenase resistant 
(45, 185) FdoG formate dehydrogenase resistant 
(45, 185) FhuD hydroxamate dependent iron uptake resistant 
(185) HolD DNA polymerase III, psi subunit resistant 
(45, 185) HyaA hydrogenase 1, small subunit  resistant 
(45, 185) HybA putative hydrogenase resistant 
(45, 185) HybO putative hydrogenase resistant 
(45, 185) MdoD glucans biosynthesis resistant 
(45, 185) NapA periplasmic nitrate reductase resistant 
(45, 185) NapG ferredoxin, electron transfer  resistant 
(45, 185) NrfC formate dependent nitrate reductase  resistant 
(185) PepE alpha-aspartyl dipeptidase resistant 
(185) PepP proline aminopeptidase II  resistant 
(185) PgpB phosphatidylglycerophosphate phosphatase  resistant 
(45, 185) SufI suppressor of ftsI  resistant 
(185) ThiP thiamine transporter, ABC family  resistant 
(45, 185) TorA TMAO reductase resistant 
(45, 185) TorZ biotin sulfoxide reductase 2  resistant 
(45, 185) WcaM putative colanic acid biosynthesis  resistant 
(45) YaeI putative phosphodiesterase resistant 
(45, 185) YagT unknown resistant 
(45, 185) YahJ putative deaminase  resistant 
(185) YbfL pseudogene resistant 
(185) YbiP putative integral membrane protein resistant 
(45, 185) YcbK putative outer membrane protein  resistant 
(45, 185) YcdB putative iron dependent peroxidase resistant 
(45) YcdO unknown resistant 
(185) YcgF putative phosphodiesterase resistant 
(185) YdcG/MdoG glucan biosynthesis resistant 
(45, 185) YdhX putative oxidoreductase resistant 
(45, 185) YedY putative nitrate reductase  resistant 
(185) YidJ putative sulfatase resistant 
(185) YkfF putative prophage protein resistant 
(45, 185) YnfE oxidoreductase resistant 
(45, 185) YnfF putative dimethyl sulfoxide reductase resistant 
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in S. typhimurium and also found to be susceptible to protamine when compared to wild-
type, but not as susceptible as the ∆tatC and phoP controls (Figure 11, (15)).  
To confirm that deletion of the amiA and amiC loci was solely responsible for the 
increased susceptibility to protamine, plasmids for each gene were constructed in which 
the coding region for amiA and amiC was inserted into the IPTG-inducible pUHE21-
2lacI
q
 vector (157) to construct pUHE-amiA (pamiA) and pUHE-amiC (pamiC), 
respectively. Introduction of the plasmids into their respective mutants restored resistance 
of each mutant to wild-type levels (Figure 11, (15)).  
Both amiA and amiC encode N-acetylmuramoyl-L-alanine amidases that cleave the bond 
between the L-alanine and N-acetylmuramoyl residues of the peptidoglycan matrix (51, 
60) and are transported to the periplasm by the Tat system (51, 61). The redundant 
function of these amidases suggested that there could be an additive effect when both loci 
were deleted in a single strain. Data supported this hypothesis because deletion of both 
amiA and amiC genes (amiA amiC) in a single strain was more susceptible to protamine 
than either single mutant, which could be rescued to single deletion-mutant levels when a 
plasmid harboring either gene was introduced (Figure 11, (15)). Interestingly, the amiA 
amiC double mutant was not as susceptible to protamine as the tatC mutant suggesting 
that there may be an additional Tat- dependent substrate(s) required for resistance to 
protamine. This prompted an investigation to identify the potential substrates. 
Analysis of Tat double and triple mutant susceptibility to protamine 
It is plausible that AmiA and AmiC are not the only Tat-dependent substrates responsible 
for bacterial resistance to protamine. It is possible that other substrates contribute to 
resistance to a lesser extent than AmiA and AmiC; therefore, the individual deletion may  
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Figure 11. Complementation of protamine sensitivity.  
Susceptibility of Salmonella ΔphoP, Δ tatC, Δ amuA, Δ amiC, andΔ amiA ΔamiC 
mutants to protamine can be rescued by a plasmid harboring a wild-type copy of the 
respective gene. 
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not have an obvious phenotype. To explore this possibility, individual deletion of E. coli 
genes encoding Tat-dependent substrates were introduced into an amiA amiC double 
mutant. Triple mutants were then challenged against protamine to determine if the triple 
mutant would render cells more susceptible to the AMP than the amiA amiC double 
mutant. Indeed, deletion of citE, fdnG, hyaA, sufI, wcaM, yaeI, yagT, yahJ, ybiP, ycbK, 
yedY, or ynfE in the amiA amiC strain increased susceptibility to protamine compared 
to amiA amiC double mutant (Figure 12, top). Notably, several of these loci encode 
products that function in cellular respiration. Therefore, it was postulated that deletion of 
tatC has a negative effect on cellular respiration, which makes cells susceptible to AMPs.  
A systematic analysis was conducted in which double mutants of genes encoding Tat-
dependent substrates involved in cellular respiration were constructed. The double 
mutants were then challenged against protamine to determine if cells were susceptible 
compared to the isogenic wild-type. Deletion of both napA and ynfF (ΔnapA ΔynfF) in a 
single strain rendered cells more susceptible to protamine, however, not as susceptible as 
the ΔtatC mutant strain (Figure 12, bottom). It remains to be determined how napA, 
which encodes a periplasmic nitrate reductase, and ynfF, which encodes a paralog of the 
DmsA dimethyl sulfoxide reductase (186), together contribute to resistance to protamine. 
These enzymes are similar in that they require molybdenum cofactors for reduction of 
nitrate (187, 188). However, nitrate is generally reduced in anaerobic conditions 
suggesting that these enzymes can function in aerobic processes or the presence of 
protamine mimics an anaerobic environment, i.e., protamine targets cellular respiration 
(discussed in Chapter 1) and, as a result, may impede the use of oxygen as an acceptor in 
the electron transfer chain. This hypothesis is supported by the following observations: 
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Figure 12. Protamine sensitivity assay of Tat-dependent mutants.  
(top) Protamine susceptibility assay of amiA amiC triple mutants. Deletion of citE, 
fdnG, hyaA, sufI, wcaM, yaeI, yagT, yahJ, ybiP, ycbK, yedY, or ynfE in a amiA amiC 
background increases susceptibility to protamine, similarly as tatC mutant. Solid red 
circle, WT; dashed red circle, tatC mutant; long dashed red circle, amiA amiC 
mutant; dashed green circle, amiA amiC triple mutant. (bottom) Protamine 
susceptibility assay using double mutants of genes encoding Tat-dependent substrates 
involved in cellular respiration demonstrates that deletion of both napA and ynfF results 
in increased susceptibility to protamine. (bottom, left) Double mutants were spotted onto 
LB agar plates with various concentrations of protamine. Solid red circle, WT; dashed 
red circle, tatC mutant; dashed green circle,napA ynfF mutant. (bottom, right) 
Determination of cfu survival of tatC, napA, ynfF and napA ynfF. 
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(i) protamine (at a concentration within the range tested in this study) has been previously 
demonstrated to inhibit oxygen consumption (189); (ii) deletion of the F1F0-ATPase 
(which abolishes the production of ATP via oxidative phosphorylation) increases E. coli 
susceptibility to protamine (Figure 2) presumably due to the inefficient production of 
ATP from substrate-level phosphorylation; and, (iii) supplementation of formate or 
succinate, organic acids oxidized in the tricarboxylic acid cycle, (which should increase 
the production of ATP via substrate-level phosphorylation) is able to protect bacterial 
cells from the oxygen consumption inhibitory effects of  human bactericidal/ 
permeability-increasing protein (BPI) and increase bacterial survival in the presence of 
BPI (170) and protamine (Figure 2). Nevertheless, it remains to be determined how these 
nitrate-reducing enzymes facilitate protamine resistance since exogenous nitrate was not 
added to the bacteria-AMP challenge systems. 
Conclusion 
Cumulatively, the data presented here demonstrate the importance of the Tat system in 
bacterial resistance to AMPs. The Tat system transports proteins involved in various 
cellular functions (reviewed in (47)); therefore, it stands to reason that the absence of the 
Tat system as a whole, and not just individual substrates, is detrimental to bacterial cells 
in the presence of AMPs. Nevertheless, it is clear that peptidoglycan amidase, AmiA and 
AmiC, as well as two nitrate-reducing enzymes, NapA and YnfF, contribute to the Tat-
dependent resistance since deletion of genes encoding these enzymes increases bacterial 
susceptibility to protamine.  
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CHAPTER 3 
GENETIC AND BIOCHEMICAL ANALYSIS OF NOVEL CPXR/A-DEPENDENT 
LOCI REQUIRED FOR BACTERIAL RESISTANCE TO ANTIMICROBIAL 
PEPTIDES 
Introduction 
The Escherichia coli cpxRA operon encodes a two-component system comprised of a 
sensor kinase, CpxA, and its cognate response regulator, CpxR, that controls a specific 
set of genes in response to cell envelope stress caused by several factors, including 
alkaline pH, high osmolarity, inner membrane disruptions, misfolded proteins, and 
starvation (reviewed in (10)). CpxR/A represents one of three characterized stress 
response systems, including BaeRS and σE, that work coordinately and individually to 
maintain cell envelope integrity under various harsh extracytoplasmic conditions. 
Specifically, CpxR/A has been suggested and experimentally demonstrated to contribute 
to bacterial virulence discussed in (190)), biofilm formation (13), and chemotaxis (14), 
by upregulating a multitude of genes in response to their respective signals. Recently, 
CpxR/A has been demonstrated to facilitate bacterial resistance to various classes of 
antimicrobial substances, including antimicrobial peptides ((15) and this chapter) and 
antibiotics (17-20) by upregulating target promoters; meanwhile facilitating the 
bactericidal effects of peptidoglycan recognition proteins (PGRPs) (21) and certain 
classes of antibiotics (22). 
CpxR-dependent regulation of amiA and amiC promoters 
Genetic screen to identify transcriptional regulators of amiA and amiC. As described in 
Chapter 2, two N-acetylmuramoyl-L-alanine amidases, encoded by amiA and amiC, are 
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required for bacterial resistance to AMPs because deletion of amiA and amiC resulted in 
increased susceptibility to protamine (Figure 11). To gain insight regarding the 
regulatory mechanism in which these amidases work to confer bacterial resistance to 
AMPs, regulatory factors were sought to determine how these genes were regulated. To 
identify putative transcriptional regulators of amiA and amiC, a blue/white genetic screen 
was carried out using chromosomal lac fusions (156) constructed at both Salmonella 
typhimurium loci (to generate ∆amiA-lac and ∆amiC-lac) and a plasmid library 
(constructed with the multi-copy number plasmid, pUC19) introduced into each strain. 
The premise of the screen (illustrated in Figure 13) was that if an activator was 
overexpressed, it would increase transcription of its target genes. Thus, the lac fusion 
would produce more β-galactosidase which could be visualized by cells with an intense 
blue color when plated on media containing X-gal, an analog of the natural substrate of β-
galactosidase, lactose. On the other hand, if a repressor was overexpressed, the lac fusion 
would produce less β-galactosidase which could be visualized by a white color when 
plated on media containing X-gal. It was unlikely that a repressor would be identified due 
to the relatively low level of transcription from the lac fusions (<15 Miller Units); 
therefore, efforts were focused on identifying putative activators.  
Characterization of chromosomal regions that increase transcription of amiA and amiC. 
To identify the activator(s) of amiA and amiC, plasmids of dark blue colonies were 
isolated and sequenced to identify the DNA sequence that was overexpressed. Multiple 
plasmids selected from dark blue colonies contained a Salmonella typhimurium LT2 
chromosomal region from 281130 to 283006 in the ∆amiA-lac strain (Figure 14). This 
region contains two open reading frames, yaeJ and nlpE, which forms an operon with  
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Figure 13. Schematic of screen to identify amiA and amiC activators. 
Illustration of the blue/white screen conducted to identify potential transcriptional 
activators of amiA and amiC. 
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yaeQ on the chromosome (191). To determine which gene was responsible for the 
activation, yaeJ and nlpE were each cloned into the IPTG-inducible pUHE21-2lacI
q
 
vector (157) to obtain pUHE-yaeJ (pyaeJ) and pUHE-nlpE (pnlpE). The resulting 
plasmids were introduced into the ∆amiA-lac strain and β-galactosidase activity was 
determined. 
Overexpression of nlpE, but not yaeJ, was able to activate ∆amiA-lac transcription 
because β-galactosidase activity was detected only when nlpE was overexpressed (Figure 
14, (15)). Interestingly, chromosomal fragments representing the same chromosomal 
region were isolated and characterized from dark blue colonies in the ∆amiC-lac library. 
As expected, overexpression of nlpE, but not yaeJ, was able to increase ∆amiC-lac 
transcription because β-galactosidase activity increased 5- to 6-fold when compared to 
the vector only control (Figure 14, (15)). NlpE is a lipoprotein involved in copper 
homeostasis and adhesion (192, 193) and has been reported to stimulate the regulatory 
activity of the CpxR/A system (194).  Therefore, it was hypothesized that induction of 
amiA and amiC transcription by nlpE overexpression was dependent on CpxR. To 
determine this, the cpxR locus was deleted in both ∆amiA-lac and ∆amiC-lac strains 
containing pnlpE. As expected, deletion of cpxR prevented induction of both loci by nlpE 
(Figure 15, (15)), further suggesting that the Cpx system transcriptionally regulates these 
genes. 
Analysis of CpxR-dependent regulation of amiA and amiC. To further determine the role 
of CpxR in the regulation of amiA and amiC, in vitro assays were performed to ascertain 
the specificity of CpxR-dependent activation of amiA and amiC. First, transcription start 
sites for each gene were identified via primer extension. To further establish CpxR-  
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Figure 14. Chromosomal region that activates amiA and amiC.  
(top) Chromosomal region contained in a plasmid identified in the screen that activates 
ΔamiA-lac contains two genes, yaeJ and nlpE. (bottom) β-galactosidase activity of 
ΔamiA-lac and ΔamiC-lac harboring a vector or plasmids containing yaeJ (pyaeJ) or 
nlpE (pnlpE) determines that nlpE is responsible for the activation of ΔamiA-lac and 
ΔamiC-lac (15). 
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Figure 15.  CpxR/A-dependent induction of amiA and amiC.  
β-galactosidase activity of ΔamiA-lac (top) and ΔamiC-lac (bottom) harboring a control 
plasmid (vector) or plasmids containing yaeJ (pyaeJ) or nlpE (pnlpE) in a wild-type and 
ΔcpxR background. Overexpression of nlpE, but not others, can activate transcription in a 
wild-type but not ΔcpxR background (15). 
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dependent expression, RNA was isolated from wild-type vector, wild-type pnlpE, and 
ΔcpxR pnlpE strains and reverse transcribed using 32P-labeled primer 1472 to generate 
32
P-cDNA of the putative amiA promoter. Samples were analyzed on a 6% acrylamide-
urea gel in which cDNA fragments ran according to their size in length (representing the 
transcription start site) and compared to a ladder generated from a Maxam and Gilbert 
A+G reaction. The amiA promoter generated two transcript products located 71 and 62 bp 
upstream of the start codon (Figure 16, (15)) suggesting that transcription could be 
initiated from two locations. Additionally, the cDNA level of both transcripts increased 
when nlpE was overexpressed in wild-type, but not in ΔcpxR, further demonstrating 
CpxR-dependent activation of amiA transcription. Meanwhile, a single transcript located 
220 bp upstream of the amiC start codon was characterized using 
32
P-labeled primer 1482 
(Figure 16, (15)). Likewise, the cDNA level was significantly increased in a CpxR-
dependent manner when nlpE was overexpressed.  
Further analysis of the putative amiA and amiC promoter regions established by the 
primer extension analysis were carried out. In silico analysis revealed the presence of two 
imperfect direct repeat sequences (Figure 17, top), 5’-GAAAT-N5-GTAAA-3’ (solid 
box) and   5’-GTATT-N5-GAAAA-3’ (dashed box) located 96 bp and 101 bp, 
respectively, upstream of the amiA start codon. These sequences are similar to the well-
established CpxR consensus sequence, 5’-GTAAA-N5-GTAAA-3’ (195), suggesting that 
CpxR could directly bind to these sequences. To determine the specific nucleotide 
sequence in which CpxR binds, DNase I footprinting assays were carried out using 
purified His6-CpxR protein and DNA generated with primers 
32
P-1567 and 1472 for the 
coding strand and 
32
P-1472 and 1567 for the noncoding strand that represent the putative 
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Figure 16. Primer extension analyses of amiA and amiC promoters.  
Primer extension analysis of amiA (left) and amiC (right)  transcripts. mRNA was 
isolated from wild-type vector, wild-type pnlpE, and cpxR pnlpE backgrounds and 
reverse transcribed using 
32
P-labeled primers. cDNA samples were ran against a ladder 
(AG) prepared from DNA synthesized from the same 
32
P-labeled primers. (left) Analysis 
of the amiA promoter provides evidence of two transcription start sites located 71 and 62 
bp upstream of the start codon. (right) Analysis of the amiC promoter provides evidence 
of a transcription start site located 220 bp upstream of the start codon (15). 
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amiA promoter region.  As predicted, the His6-CpxR protein was able to protect the amiA 
promoter region from -118 to -74 (numbering from the amiA start codon) in the coding 
strand, and the -106 to -80 region in the noncoding strand (RI, Figure 17), which 
includes the predicted CpxR binding sites.  The predicted CpxR box located from -96 to -
82 in the amiA promoter is located upstream of the putative -10 and partly overlaps with 
the putative -35 regions for 70 to start transcription from -62 (nucleotide G, Figure 17). 
The other predicted CpxR box located from -101 to -87 is located between the alternative 
putative -10 and -35 regions and remains to be determined if it is involved in 
transcription initiated from -71 (nucleotide T, Figure 17). It is clear, however, that the 
sequence representing RI is required for CpxR binding because substitution of RI 
abolishes His6-CpxR protection from DNase I (Figure 17). An additional region (RII, 
Figure 17), was weakly protected by CpxR. However, due to its location downstream of 
the transcription start site and lack of a homologous CpxR box, it is unlikely to have a 
CpxR-dependent regulatory function. 
Likewise, an in silica analysis revealed a putative CpxR box, 5’-ATAAA-N5-GTAAA-3’, 
located 250 bp upstream of the amiC start codon and on the opposite strand (Figure 18, 
top). DNase I footprinting analysis was conducted using DNA generated with primers 
32
P-1484 and 1482 for the coding strand and 
32
P-1482 and 1484 for the noncoding strand. 
The analysis demonstrated that His6-CpxR protein could protect the amiC promoter 
region from -257 to -232 of the coding strand and from -257 to -232 of the noncoding 
strand (R, Figure 18) which includes the putative CpxR box. Thus, the CpxR box is 
located on the opposite strand and between the -35 and -10 regions relative to the 
identified transcription start site at -220 (nucleotide T, Figure 18). Additionally, CpxR 
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Figure 17. Analysis of the amiA promoter.  
(top) In silico analysis of the amiA promoter reveals the presence of two putative CpxR 
binding sites (boxed) relative to the two identified transcription start sites (uppercase and 
bold nucleotides) and the start codon (uppercase, ATG). The underlined region represents 
the sequence protected by CpxR after DNase I digestion (single underline, protected 
region I (RI); double underline, protected region II (RII)). (bottom) DNase I footprinting 
assay reveals two regions protected by CpxR protein, RI and RII on the noncoding (left 
panel) and coding (middle panel) strands. Binding by CpxR is specific to the sequence 
since substitution of RI abolishes protection (right panel) (15). 
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Figure 18. Analysis of the amiC promoter.  
(top) In silico analysis of the amiC promoter reveals the presence of a putative CpxR 
binding site (boxed) relative to the identified transcription start site (uppercase and bold 
nucleotide) and the start codon (uppercase, ATG). The underlined region represents the 
sequence protected by CpxR after DNase I digestion. (bottom) DNase I footprinting 
assay reveals a region (R) protected by CpxR protein on the noncoding (left panel) and 
coding (middle panel) strands. Binding by CpxR is specific to the sequence since 
substitution of R abolishes protection (right panel) (15). 
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binding to the sequence represented by R is specific because substitution of R abolished 
His6-CpxR protection from DNase I. 
Cumulatively, these data provide evidence of CpxR-dependent regulation of the amiA 
and amiC promoters in which CpxR directly binds to a homologous CpxR box residing in 
the promoter regions to exert its regulatory activity. 
CpxR-dependent regulation of the rfe-rff gene cluster 
Rationale to study regulation of the rfe-rff gene cluster. The rfe-rff gene cluster encodes 
enzymes involved in the biosynthesis of the enterobacterial common antigen (ECA), a 
glycolipid composed of a trisaccharide repeat located on the outer leaflet of the outer 
membrane in all bacteria species of the Enterobacteriaceae family (reviewed in (54)). 
Although the physiological function of ECA remains to be determined, it has been 
implicated in bacterial resistance to bile salts (57), organic acids (56), and AMPs 
(Chapter 1) as well as virulence (57). Deletion of loci residing in the rfe-rff gene cluster 
was found to increase susceptibility to all peptide classes analyzed in this study (Figure 
7), suggesting a global contribution of their gene products to AMP resistance. Further 
analysis (discussed in Chapter 1) determined that the increased susceptibility is the result 
of the absence of ECA and not accumulation of intermediates of the ECA biosynthesis 
pathway.  
Since the biosynthesis of ECA was proposed to be required for resistance to AMPs, 
experiments were carried out to determine how the rfe-rff gene cluster is regulated since 
it had not been previously reported. An in silico analysis of the rfe promoter, the first 
gene of the cluster, revealed a putative CpxR binding site (5’-GAAAA-N5-GGAAT-3’) 
located 154 bp upstream of the start codon (Figure 19, top) suggesting that the rfe 
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promoter (and by extension, the entire rfe-rff gene cluster), may be regulated by CpxR/A,  
further demonstrating a global role for CpxR/A in resistance to antimicrobials. 
Activation of CpxR increases transcriptional expression of the rfe promoter. To 
determine if CpxR could regulate transcription of the rfe promoter, and possible  
downstream genes, chromosomal lac fusions were constructed at the rfe, rffT, and rffM 
loci to construct rfe-lac, rffT-lac, rffM-lac, respectively. Plasmid pnlpE was 
introduced into each lac fusion strain to stimulate the regulatory activity of the CpxR/A 
system (194). Overexpression of nlpE increased -galactosidase activity of rfe-lac 4-
fold, rffT-lac 2-fold, and rffM-lac 3-fold (Figure 19, bottom left). This observation is 
consistent with previous reports in which overexpression of CpxR could increase 
expression of rffA (another member of the rfe-rff gene cluster) 1.9-fold after analysis by 
qRT-PCR (196).  The increase in -galactosidase activity was dependent on CpxR as 
deletion of cpxR in each strain abolished the transcriptional increase (Figure 19, bottom 
left). Cumulatively, this demonstrates that CpxR can regulate transcription activity of 
members of the rfe-rff gene cluster (and likely the entire cluster) and postulates that the 
rfe-rff gene cluster comprises a single transcriptional operon. 
The rfe-rff gene cluster likely comprises a single transcriptional unit. To address the 
possibility that the rfe-rff gene cluster is localized in a single operon, a series of reverse 
transcription-polymerase chain reactions (RT-PCR) were conducted. Total RNA, 
extracted from wild-type, was reverse transcribed and the cDNA product was used in a 
series of PCR reactions in combination with sets of defined primers to demonstrate the 
singularity of the operon (illustrated in Figure 19, top). Specifically, primer pairs 
1912/1915, 1914/1917, 1916/1804, and 1803/1919 were used to generate products to 
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Figure 19. Cpx-dependent activation of the rfe-rff gene cluster.  
(top) In silico analysis of the rfe promoter (the first gene in the cluster) reveals a putative 
CpxR-binding site. Right-facing arrow, 5’ primer; left-facing arrow, 3’ primer. Numbers 
correspond to the primer number. (bottom, left) Overexpression of nlpE increases -
galactosidase activity of chromosomal lac constructs at the rfe, rffT, and rffM loci. 
(bottom, right) RT-PCR reveals that the rfe-rff gene cluster may comprise a single 
transcriptional unit. 
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represent the initial operon transcript, the rfe/wzzE/rffE chromosomal region (~2.2 kb, set 
A), the wzzE/rffE/rffD/rffG/rffH chromosomal region (~3.5 kb, set B), the rffG/rffH/rffC/ 
rffA/wzxE/rffT chromosomal region (~4 kb, set C), and the wzxE/rffT/wzyE/rffM 
chromosomal region (~2.5 kb, set D), respectively. Single positive bands were identified 
for sets A, B, and D (Figure 19, bottom right), suggesting that the transcripts 
represented in the primer set region comprise a single RNA transcript. Lane C generated 
multiple bands (Figure 19, bottom right); however, the longest DNA amplified migrated 
to the estimated size of a single transcript, suggesting that there may be multiple levels of 
regulation in this region of the gene cluster. Cumulatively, these data suggest that the rfe-
rff gene cluster could comprise a single transcriptional unit; however, there may be an 
additional promoter region between the rffG and rffT loci that can initiate transcription of 
a single gene or multiple genes between the loci. 
CpxR directly binds to the rfe promoter. Previous transcriptional data demonstrated that 
CpxR could activate transcription of loci within the rfe-rff gene cluster when induced by 
nlpE overexpression (Figure 19, bottom left). To determine if CpxR directly regulated 
these loci by interacting with the promoter region, an electromobility shift assay was 
performed using purified His6-CpxR protein and a 420-bp DNA fragment corresponding 
to the upstream and overlapping region of the rfe start codon (representing the putative 
promoter region). The CpxR protein was able to shift the DNA fragment (Figure 20, 
bottom left), indicating the presence of CpxR-binding sites in the rfe promoter region. 
As the amount of CpxR increased to 150 pmol, two distinct shifts were observed 
confirming direct interaction of the CpxR protein with the promoter DNA. Next, DNase I 
footprinting analysis was conducted to determine the specific nucleotide sequence 
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Figure 20. Analysis of CpxR binding to the rfe  promoter.  
(top) DNA sequence of putative rfe promoter highlighting (in purple) the putative CpxR 
binding site. (bottom, left) EMSA shows that CpxR can bind to at least two locations 
within the rfe promoter. (bottom, right) Illustration of CpxR binding to the rfe promoter 
154 bp upstream of the rfe start codon, GTG.  
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recognized by CpxR. Using purified His6-CpxR protein and DNA representing the rfe 
promoter generated with primers 
32
P-1921 and 1913 for the coding strand, protection was 
observed upstream of the rfe start codon (illustrated in Figure 20, bottom right). The 
region protected by CpxR contains an imperfect direct repeat sequence, 5’-GAAAA-N5-
GGAAT-3’, 154 bp upstream of the start codon (Figure 20, top) which is similar to the 
homologous CpxR box described previously (195). This surmounting evidence confirms 
that CpxR binds to the rfe promoter to activate transcription of the rfe locus, and likely 
the rfe-rff gene cluster. 
CpxR-dependent regulation of the marRAB operon  
Rationale to study the regulation of mar. The multiple-antibiotic resistant operon, 
marRAB, encodes a repressor, MarR, and activator, MarA, which coordinately regulate 
the mar promoter, in concert with the global regulators Rob and SoxS. It was recently 
reported that the marRAB operon could be activated by sub-lethal concentrations of 
AMPs via Rob (which is required for polymyxin B-induced upregulation of micF (43)) 
and could facilitate resistance, at least in part, by overexpressing the AcrAB/TolC efflux 
pump (44). While deletion of marA had no apparent phenotype regarding susceptibility to 
AMPs, constitutive expression of marA decreased bacterial susceptibility to AMPs in an 
AcrAB/TolC-dependent manner (discussed in Introduction). Importantly, deletion of tolC 
resulted in increased susceptibility to each AMP analyzed, however, susceptibility to 
polymyxin B could be reduced or increased in a constitutive marA background depending 
on the AMP (44). This evidence suggested that MarA-dependent genes contribute to 
bacterial resistance and susceptibility to AMPs. Cumulatively, these data launched an 
investigation to further analyze the marRAB operon for additional regulatory activities in 
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regards to bacterial resistance to antimicrobial peptides as well as the role of a 
downstream target. 
Analysis of CpxR-dependent regulation of the mar operon. The marRAB promoter has 
been extensively studied and is well characterized (31-33) (illustrated in Figure 21, top).  
In the presence of specific antibiotics, bile salts, and reactive oxygen species, MarA  (35, 
36), Rob (37, 38) and SoxS (39, 40), respectively, will bind to a 20 nucleotide sequence 
designated as the marbox (33) to activate transcription of the operon. In contrast, MarR is 
a strong repressor that binds at the operator region (dashed rectangle, Figure 21, top) 
whose effect is only alleviated when a compound, such as salicylate, binds the protein to 
result in its disassociation from the promoter to allow for transcription (31) (32, 41). 
Further examination of the promoter sequence revealed a putative CpxR-binding site 
approximately 50 nucleotides upstream of the marbox (Figure 21, top). The putative 
CpxR-box contains the sequence 5’-GTAAA-N5-ATAAA-3’ which is similar to the well 
established CpxR consensus sequence (195), making it a good candidate sequence for 
CpxR to bind.  
To determine whether CpxR can regulate the marRAB operon, a series of 
chromosomally- and plasmid-encoded lac fusions were constructed to ascertain the 
activity of the mar promoter (illustrated in Figure 21, bottom).  Chromosomal lac 
fusions (156) were constructed at each of the three loci of the mar operon to yield 
∆marR-lac (in which the MarR repressor is absent), ∆marA-lac (in which the MarA 
activator is absent), ∆marB-lac (in which MarB is absent), and ∆marRA-lac, (in which 
both the activator and repressor are absent). It was first necessary to determine whether 
these constructs could serve as suitable reporters for the mar promoter. Therefore, β- 
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Figure 21. Analysis of the marRAB promoter.  
(top) In silico analysis of the marRAB promoter region reveals a putative CpxR box 
upstream of the previously characterized marbox (purple), -35 (green), -10 (yellow), 
transcription start site (blue), operator region (underlined/dashed box), and start codon 
(GTG). (bottom) Illustration of the chromosomally- and plasmid-encoded lac fusions 
constructed to analyze the transcriptional activity of the mar promoter.  
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galactosidase activity was determined in the presence of salicylate, a gratuitous inducer 
of the mar promoter (32), to confirm that expression could be increased. Expression 
increased 28-fold in the ∆marA-lac strain when saliciylate was present; however, no 
significant increase in expression of the ∆marR-lac, ∆marB-lac or ∆marRA-lac 
constructs was observed (Figure 22, top). While it was concluded that ∆marB-lac could 
not serve as a suitable reporter for the mar promoter, it was deduced that the lack of 
induction by salicylate in ∆marR-lac and ∆marRA-lac was due to constitutive expression 
of the promoter because of the lack of the MarR repressor. Therefore, ∆marA-lac, and 
perhaps ∆marR-lac and ∆marRA-lac, were determined to be adequate reporters to 
measure mar promoter expression levels.  
Next, pnlpE was introduced into each chromosomal lac fusion strain to determine if 
CpxR could activate transcription of these reporters. Overexpression of nlpE increased β-
galactosidase activity of ∆marR-lac 3- fold and ∆marRA-lac 3.8- fold when compared to 
the vector only control (Figure 22, bottom), suggesting that CpxR could activate 
transcription of this operon. This increase in expression was abolished when cpxR was 
deleted, confirming CpxR-dependent activation of this operon via nlpE overexpression. 
Interestingly, pnlpE had no effect on ∆marA-lac transcription (nor ∆marB-lac which was 
previously demonstrated to be an inadequate reporter for the mar promoter) (Figure 22, 
top). These data posit two regulatory mechanisms: (i) CpxR-dependent activation of the 
mar promoter facilitated by MarA since deletion of marA abolishes the transcriptional 
induction by nlpE overexpression; (ii) CpxR-MarA and MarR participation in an 
antagonistic relationship because in the absence of marA, CpxR cannot exert its 
regulatory activity unless MarR is also absent (illustrated in Figure 22, bottom). 
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Figure 22. β-galactosidase activity of chromosomal mar promoter constructs. 
(top) Expression of ∆marA-lac increased when saliciylate, a well-known inducer of the 
mar promoter, was supplemented. However, no significant increase in expression of 
∆marR-lac, ∆marB-lac or ∆marRA-lac was observed. (bottom) Overexpression of nlpE 
(pnlpE) is able to increase transcription of the mar promoter in ∆marR-lac and ∆marRA-
lac in a CpxR-dependent manner, however, is unable to increase transcription of ∆marA-
lac or ∆marB-lac. 
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To further analyze the effect of CpxR on transcriptional activity of the mar promoter, 
plasmid-encoded lac fusions (pYS1734 and pYS1736) were constructed which contain 
different lengths of the mar promoter followed by the lac coding region (illustrated in 
Figure 21, bottom). The longest promoter region represented in pYS1734 contains an 
extension of the previously characterized mar promoter (32) as it contains 540 bp 
upstream of the transcription start site and thus carries the marbox and the putative CpxR-
binding site. Meanwhile, plasmid pYS1736 contains only 120 bp upstream of the 
transcription start site and therefore contains the marbox, but not the putative CpxR-
binding site. To ascertain whether these constructs could serve as suitable reporters for 
the mar promoter, β-galactosidase activity was determined in the presence of salicylate to 
confirm that expression could be increased. Indeed, the presence of salicylate increased 
expression of pYS1734 2.6-fold and expression of pYS1736 2.2-fold (Figure 23, top), 
which is less than previous reports of 5-10-fold induction by salicylate (32, 42); however, 
these data were determined to be significant via Student’s t-Test (p = 0.0035 and 0.0023, 
respectively). Next, pnlpE was introduced into strains harboring either plasmid and β-
galactosidase activity determined. Overexpression of nlpE increased expression of 
pYS1734 2.8-fold and pYS1736 2.6-fold, when compared to the vector only control 
(Figure 23, bottom), suggesting that CpxR could activate transcription of this operon. 
This increase in expression was abolished when cpxR was deleted, confirming CpxR- 
dependent activation of the mar promoter via nlpE overexpression. It was unexpected 
that nlpE overexpression could increase transcriptional activity of pYS1736 since this 
plasmid doesn’t contain the putative CpxR box. Therefore, it was hypothesized that CpxR 
could bind the mar promoter region downstream of the predicted CpxR box, within the 
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Figure 23. β-galactosidase activity of plasmid mar promoter constructs.  
(top) Plasmids pYS734 and pYS1736 are able to respond to salicylate, a well-known 
inducer of the mar promoter. (bottom) Overexpression of nlpE (pnlpE) is able to increase 
transcription of the mar promoter encoded in pYS1734 and pYS1736 in a CpxR-
dependent manner. 
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chromosomal region represented in pYS1736.  
It is noteworthy to mention that while MarA has been shown to activate the marRAB 
promoter in the presence of specific signaling molecules, it is unclear whether MarA is 
required for activation of the promoter in the absence of the MarR repressor. In other 
words, it is unclear whether the absence of MarR is sufficient to activate transcription of 
the operon, or if activators, such as MarA are still required. The data presented suggest 
that MarA plays a role, but is not absolutely required, in MarR-depleted conditions to 
activate transcription of the promoter. This is demonstrated in both the chromosomal- and 
plasmid-encoded lac fusions. When comparing marR-lac with marRA-lac in non-
inducing conditions, -galactosidase activity is reduced ~2-fold in non-inducing 
conditions when marA is absent (Figure 24). Additionally, when measuring -
galactosidase activity of pYS1734 in marR and marRA backgrounds, expression is 
reduced ~ 2.5-fold in non-inducing conditions when marA is deleted (Figure 24). Thus, 
MarA likely plays a role, but is not required for transcription of marRAB in the absence 
of the MarR repressor because transcription still occurred in the absence of MarA. 
It was previously mentioned that MarA may facilitate CpxR binding to the mar promoter 
to exert its regulatory effect in the presence of the MarR repressor. CpxR has been 
previously shown to facilitate BaeR-dependent regulation of acrD and mdtABC 
promoters which encode drug efflux systems (17, 18). Therefore, to ascertain the CpxR- 
dependent activation in relation to the known regulators of the mar operon, expression of 
each plasmid-encoded fusion was determined in wild-type, ∆marA, ∆marR, ∆marRA, 
∆rob and ∆soxS backgrounds, each overexpressing nlpE, to determine if CpxR could 
directly influence the mar promoter activity or if the activation is facilitated by other mar 
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Figure 24. -galactosidase activity comparing marR and marRA. 
-galactosidase activity comparing marR and marRA backgrounds demonstrate that 
MarA plays a role in transcription of the marRAB promoter in non-inducing conditions in 
the absence of MarR, but is not solely required. 
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regulators. Deletion of marA and rob reduced the transcription induction by pnlpE to 
1.38-fold and 1.27-fold, respectively in pYS1734 and 1.3-fold and 2.0-fold, respectively 
in pYS1736 (Figure 25), suggesting that CpxR regulation of the mar promoter is 
dependent on either MarA and/or Rob activators. Meanwhile, deletion of marR or soxS 
maintained CpxR-dependent induction by nlpE overexpression (Figure 25). Interestingly, 
deletion of marRA (in which both MarR and MarA is absent) did not abolish induction by 
nlpE (Figure 25) demonstrating that in the presence of MarR, MarA is required for 
CpxR-dependent induction, however, MarA is not required in the absence of MarR 
(illustrated in Figure 26).  
Biochemical evidence of CpxR-dependent regulation of mar. As previously mentioned, an 
in silico analysis of the mar promoter revealed a putative CpxR binding site, 5’-GTAAA-
N5-ATAAA-3’, located 50 bp upstream of the marbox.  An electromobility shift assay 
(EMSA) was carried out to determine if purified CpxR protein could directly bind to a 
DNA fragment, generated with primers 1723 and 1725, representing the mar promoter. 
Indeed, two DNA shifts were observed (Figure 27, bottom left) when increasing 
amounts of CpxR protein were added to the system, indicating the likelihood of two (or 
more) CpxR binding sites within this sequence. To determine the nucleotide sequence to 
which CpxR binds within the mar promoter, a DNase I footprinting assay was carried out 
using purified His6-CpxR protein and DNA generated from primers 
32
P-1723 and 1725 
for the coding strand and 
32
P-1725 and 1723 for the noncoding strand. CpxR was able to 
protect DNA from DNase I cleavage in three regions (numbering from the start codon): -
96 to -115 (RI), -140 to -164 (RII), and -215 to -239 (RIII) on the coding strand; and -56 
to -65 (RI), -110 to -117 (RII), and -145 to -165 (RIII) on the noncoding strand (Figure  
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Figure 25. β-galactosidase activity of mar promoter with deleted regulators.                   
β-galactosidase assays to determine the effect of mar promoter regulators on CpxR-
dependent induction when nlpE is overexpressed (pnlpE) using the plasmid-encoded lac 
constructs pYS1734 (top) and pYS1736 (bottom). 
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Figure 26. Illustration of CpxR regulation of the marRAB promoter.  
In the presence of both MarA and MarR, CpxR can induce basal-level expression (top, 
left). In the presence of MarR but absence of MarA, CpxR is not sufficient to induce 
expression, therefore, transcription remains at basal levels (top, right). In the absence of 
MarR, CpxR is able to induce constitutive expression regardless of the absence or 
presence of MarA (bottom). 
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28). Each region is located upstream of the marbox, and thus, upstream of the reported 
transcription start site indicating that these regions can serve as regulatory elements for 
CpxR. Moreover, regions RII and RIII contain sequences similar to the consensus CpxR 
box. RII contains 5’- CTTGA-N5-TTTAG-3’ located 107 bp upstream of the start codon, 
overlapping the marbox, and on the opposite strand; while RIII contains 5’-GTAAA-N5-
ATAAA-3’ located 162  bp upstream of the start codon. Thus, these two sequences likely 
contribute to CpxR-dependent regulation of mar. Notably, the RII protected sequence is 
present in pYS1736 and thus explains why overexpression of nlpE is able to increase 
transcription of the mar promoter construct. Cumulatively, these data demonstrate that 
CpxR can directly bind to the mar promoter to activate transcription of the marRAB 
operon. 
Identification of a CpxR/A signal  
Rationale to identify the physiological signal for CpxR/A. Microbial two-component 
systems consist of a sensor histidine kinase/phosphatase which, upon activation by a 
signal molecule, will activate its cognate response regulator by phosphorylation and 
inactivate its regulator by dephosphorylation when the signal is removed (reviewed in 
(1)). A common challenge amongst researchers, however, is to identify the signal 
molecules that have a global effect regarding cell survival and maintenance. The cpxRA 
operon encodes a sensor, CpxA, and its cognate response regulator, CpxR, which 
globally regulates a vast number of promoters in response to periplasmic stress, including 
misfolded proteins, inner membrane disruptions, alkaline pH, starvation, and high 
osmolarity (reviewed in (10)). While the physiological signal for CpxA has not been 
identified, Cpx-dependent regulation continues to be characterized as its regulon 
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Figure 27. Biochemical analysis of CpxR binding to the mar promoter.  
(top, left) EMSA shows that CpxR can bind to at least two locations within the mar 
promoter. Binding is specific because competition with unlabeled DNA (cold-DNA) 
abolishes the shift. (bottom, left) Analysis of CpxR binding to the marRAB promoter 
relative to the previously characterized marbox (purple), -35 (green), -10 (yellow), 
transcription start site (blue), operator region (underlined), and start codon (GTG). RI, 
RII, RIII, RIV represent the regions protected by CpxR in the DNase I footprinting 
analysis. Long dashed box, putative CpxR binding site originally hypothesized. Short 
dashed box, putative CpxR binding site identified after the analysis. (right) DNase I 
footprinting analysis reveals multiple sites of CpxR protection; RII and RIII protected 
regions are found on both the coding and noncoding strands. 
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continues to grow. Additionally, the natural signal for the marRAB operon has not been 
identified as it remains to be investigated whether plant-derived napthoquinones are 
natural inducers (197). Compounds such as salicylate (SAL), chloramphenicol and 
tetracycline, acetaminophen, sodium benzoate, 2,4-dinitrophenol, cinnamate, and 
carbonyl cyanide m-chlorophenylhydazone, menadione and plumbagin have been shown 
to activate the operon (198). Recently, several aromatic amino acid metabolites were 
characterized and shown to activate the mar promoter (42). Specifically, salicylate-like 
compounds including 2,3-dihydroxybenzoate (DHB) and anthranilate (ANT) could 
activate the mar promoter (42). In addition, DHB was found to activate the promoter by 
directly binding to MarR with a similar affinity as SAL, while ANT could not, indicating 
that the efforts by ANT are independent of MarR (42). ANT is an early intermediate 
product of the tryptophan biosynthesis pathway (Figure 28) and was reported to inhibit 
growth of an E. coli ΔcpxRA mutant (199).  
Cumulatively, several intermediates of the tryptophan biosynthesis pathway have been 
shown to induce multidrug resistance in E. coli. As previously mentioned, ANT activates 
the mar promoter to increase intrinsic multidrug resistance (42). Additionally, indole 
(IND), a late intermediate product of the tryptophan biosynthesis pathway (Figure 28), 
can activate the mdtE promoter, which encodes a xenobiotic exporter, independently of 
the EvgA regulator (17). Likewise, IND can activate the BaeR/BaeS two component 
system which specifically binds to and activates target promoters including other 
xenobiotic exporters, acrD and mdtABC, interestingly mediated by CpxR (17). 
Chorismate serves as a precursor for aromatic amino acids, phenylalanine, tyrosine, and 
tryptophan; as well as IND, ANT, DHB and SAL. Deletion of the CpxR-dependent aroK 
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Figure 28. Tryptophan biosynthesis pathway. 
The tryptophan biosynthesis pathway generates intermediates previously demonstrated to 
activate the mar operon and confer multidrug and antimicrobial resistance. 
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gene (195) (which encodes an secondary kinase that catalyzes an early step in chorismate 
biosynthesis: shikimate to shikimate 3-phosphate, Figure 28), resulted in increased 
susceptibility to protamine (APPENDIX D). Taken together, these reports suggested a 
novel, physiological signal for the CpxR/CpxA system to mediate resistance to 
antimicrobial substances because (i) aromatic metabolites could activate the mar locus, 
(ii) CpxR regulates an enzyme (AroK) involved in the biosynthesis of aromatic 
metabolites but suggested to have an additional physiological role, (iii) deletion of cpxRA 
results in increased susceptibility to an aromatic metabolite (ANT), and (iv) an aromatic 
metabolite (IND) was found to mediate multidrug resistance with CpxR.  
Investigation of aromatic metabolites as signals for CpxR/A. To ascertain if aromatic 
metabolites could serve as an activation signal for the CpxR/A, chromosomal lac fusions 
of the Cpx-dependent loci cpxP (cpxP-lac, (200, 201)) and degP (degP-lac, (55, 201)) 
were used to determine if transcription could be increased in the presence of aromatic 
metabolites, ANT, IND, and SAL. -galactosidase activity of cpxP-lac was increased 
3.9-fold, 2.9-fold, and 2.2-fold in the presence of ANT, IND and SAL, respectively 
(Figure 19, top). Induction by IND was shown to be significant with a Student’s t-Test in 
which the p= 0.001; however, not significant for ANT and SAL (p= 0.22 and 0.04, 
respectively) indicating that IND can serve as a signal for CpxR/A.  Likewise, IND 
significantly increased -galactosidase activity of degP-lac 3.4-fold (p= 0.0099), while 
ANT and SAL were unable to increase activity (Figure 29, top), providing additional 
evidence that IND can serve as a signaling cue for the Cpx system. As a positive control, 
marA-lac and pYS1734 were used since SAL and ANT have previously been 
determined to induce expression of the mar operon (32, 42). Indeed, the presence of SAL 
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Figure 29. Induction of β-galactosidase activity by aromatic metabolites.  
(top) IND is able to significantly induce expression of cpxP-lac and degP-lac reporters, 
but not ANT or SAL. IND, ANT, and SAL are all able to induce expression of the mar-
lac consructs, marA-lac and pYS1734 controls, but not mgrB-lac. (bottom) Induction 
by IND is independent of CpxR since deletion of cpxR is not sufficient to abolish IND-
dependent induction. DMSO, Dimethyl sulfoxide ; ANT, anthranillate; IND, indole; 
SAL, salicylate. 
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increased transcription of marA-lac and pYS1734 26.5-fold and 4.7-fold, respectively, 
while ANT increased transcription 57.1-fold and 3.2-fold, respectively (Figure 29, top). 
Interestingly, IND was also able to significantly increase transcription of both marA-lac 
and pYS1734 4-fold and 5-fold, respectively (Figure 29, top), thus providing evidence of 
IND as an additional inducer of the mar operon, as well as the CpxR/A system. Notably, 
mgrB-lac, a PhoP-dependent (202) construct served as a negative control. None of the 
aromatic metabolites were able to significantly increase -galactosidase activity 
suggesting that the IND induction is specific to the CpxR/A and Mar systems and not a 
general transcriptional phenomenon. 
Since IND was demonstrated to be a signal for the mar promoter and the CpxR/A system, 
an investigation was carried out to determine if the induction was dependent on the 
CpxR/A system directly. ∆cpxR was introduced into each strain to yield cpxP-lac ∆cpxR, 
degP-lac ∆cpxR, and ∆cpxR pYS1734; -galactosidase activity was once again 
determined in the presence of IND. Except in cpxP-lac ∆cpxR in which deletion of cpxR 
completely abolishes transcription of cpxP, each lac construct was able to be induced in 
the presence of IND (Figure 29, bottom) suggesting that the induction by IND is 
independent of CpxR/A. While CpxR/A was not the direct system mediating the response 
to IND, it is noteworthy to determine that IND can activate both the CpxR/A system and 
the mar operon. The mechanism by which IND induces expression of these systems 
remains to be investigated. An analysis was carried out in which simultaneous deletion of 
cpxR and a gene encoding a regulator of a known two-component system in the degP-lac 
strain was assayed to determine if transcription induction by IND could be eliminated. 
Independent deletion of known two-component system regulators in degP-lac ∆cpxR was 
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not sufficient to abolish IND-dependent induction (data not shown) suggesting that 
another regulatory system mediates induction. 
Conclusion 
The E. coli CpxR/CpxA two-component system regulates a set of genes in response to 
general periplasmic stress (reviewed in (10)). As the Cpx regulon continues to be 
expanded (to date, there are over 150 demonstrated or putative members (APPENDIX 
E)), the vastness of its circuitries becomes evident as it continues to be implicated in 
virulence (reviewed in (10)), biofilm formation (13), chemotaxis (14) and recently, 
resistance to antimicrobials (15, 16, 18, 20), therefore having a global effect in signal 
transduction pathways and bacterial resistance.  
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CHAPTER 4 
CHARACTERIZATION OF CPXR/A-DEPENDENT LOCI REQUIRED FOR 
BACTERIAL RESISTANCE TO ANTIMICROBIAL PEPTIDES 
Introduction 
Many studies have focused on the characterization of the CpxR/CpxA two-component 
system. CpxR/A globally regulates a vast number of promoters in response to periplasmic 
stresses caused by misfolded proteins, inner membrane disruptions, alkaline pH, 
starvation, and high osmolarity (reviewed in (10)). Moreover, CpxR/A appears to 
contribute globally to Escherichia coli resistance to antimicrobial peptides (AMPs) since 
deletion of cpxR or cpxA increased bacterial susceptibility to RTD-2 and OH-CATH30 
(APPENDIX D). Additionally, Chapter 3 characterized new members of the CpxR/A 
regulon, including amiA, amiC, marRAB, and the rfe-rff gene cluster. Furthermore, 
analysis of the systematic screen carried out in Chapter 1 identified six candidates (aroK, 
degP, dnaK, dsbA, tolC, and yqjA) that were previously characterized as part of the 
CpxR/A regulon, further suggesting that CpxR/A could play a global role in bacterial 
resistance to AMPs. 
Characterization of CpxR/A-dependent loci required for bacterial resistance to 
antimicrobial peptides 
The notion that the CpxR/A system could be a major contributor to E. coli resistance to 
AMPs led to further analysis of the gene candidates identified in the systematic screen in 
Chapter 1. Six of those members, as well as those identified in Chapter 3 (Table 8), were 
found to contribute to bacterial resistance to AMPs because deletion of the genes resulted 
in increased susceptibility. Although several CpxR/A-dependent loci were identified as  
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Table 8. CpxR/A-dependent loci required for resistance to protamine 
Gene Function 
amiA N-acetylmuramoyl-L-alanine  amidases 
amiC N-acetylmuramoyl-L-alanine amidase 
aroK shikimate kinase involved in tryptophan biosynthesis 
degP proteinase/chaperone 
dnaK Hsp70 molecular chaperone 
dsbA disulfide isomerase  
rfe-rff enterobacterial common antigen biosynthesis 
tolC outer membrane pore involved in efflux 
yqjA DedA-like predicted inner membrane protein 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
109 
contributing to bacterial resistance to AMPs, it does not infer that they work together to 
contribute to resistance. 
Identification of multiple CpxR/A-dependent pathways that contribute to bacterial 
resistance to AMPs. To determine if the CpxR/A-dependent genes (or gene products) 
contribute to bacterial resistance to AMPs cooperatively or independently of each other, 
double mutants were systematically constructed in which each mutant, except members 
of the rfe-rff gene cluster, were crossed with one another to generate each combination of 
double mutants. It was hypothesized that if two genes work independently, then 
simultaneous deletion of both genes would cause a synthetic phenotype and render cells 
more sensitive to AMPs than either single deletion (illustrated in Figure 30). Conversely, 
if two genes work coordinately in the same pathway to contribute to resistance, then 
simultaneous deletion of both genes would not change the sensitivity to AMPs when 
compared to either single deletion (illustrated in Figure 30). Double deletion mutants 
were challenged against the model AMP, protamine, along side their single mutant 
counterparts to determine if deletion of both genes would render cells more sensitive to 
protamine than either single deletion. Notably, the analysis suggested that both TolC and 
YqjA contribute to bacterial resistance to AMPs independently of the other CpxR/A-
dependent loci identified (illustrated in Figure 30) because simultaneous deletion of tolC 
or yqjA with each of the other mutations rendered cells more susceptible to protamine 
than either single deletion mutant. On the other hand, data suggest that amiA, amiC, 
aroK, and dnaK work coordinately in their contribution to AMP resistance (illustrated in 
Figure 30), since double deletions within this group of genes did not increase 
susceptibility to protamine. Likewise, the data suggest that dsbA, degP, and aroK  
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Figure 30. Independent and coordinate CpxR/A-dependent pathways.  
Illustration of the independent and coordinate pathways of CpxR/A-dependent loci 
required for bacterial resistance to protamine. TolC and YqjA appear to contribute to 
bacterial resistance to protamine independently than any of the other Cpx-dependent loci 
identified in the systematic analysis. On the other hand, AmiA, AmiC, DnaK, and AroK 
appear to comprise a single pathway, while DegP, DsbA, and AroK comprise an 
additional pathway. Notably, AroK contributes to resistance in both pathways, suggesting 
a vital role in the aroK gene product in resistance. (NOTE: gene products are listed 
alphabetically and do not represent the true progression of the pathway to bacterial 
resistance to AMPs). 
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contribute to bacterial resistance to protamine on the same pathway (illustrated in Figure 
30) because simultaneous double deletions did not increase susceptibility to protamine. 
Interestingly, AroK seems to play a role in both independent pathways suggesting a 
significant role of the aroK gene product.  
AroK mediated resistance to AMPs. AroK is a kinase that catalyzes the conversion of 
shikimate to shikimate-3-phosphate in an early step in chorismate biosynthesis (Figure 
28). Therefore, it can be speculated that downstream products in the chorismate 
biosynthesis, or chorismate-dependent biosynthesis pathways (such as tyrosine, 
phenylalanine, tryptophan, or siderophore biosynthesis), contribute to resistance. To 
support this claim, shikimate analogs have been synthesized and determined to have 
antimicrobial activity because they inhibit the production of downstream products of the 
chorismate biosynthesis pathway (203, 204). 
Cooperativity of AmiA, AmiC, and DnaK in resistance to AMPs. The cooperative 
contribution between the peptidoglycan amidases, AmiA and AmiC, and the molecular 
chaperone, DnaK, was apparent. AmiA and AmiC are N-acetylmuramoyl-L-alanine 
amidases transported by the twin-arginine transporter (Tat) system (51, 61), a Sec-
independent system responsible for the transport of globular proteins across the inner 
membrane (45). The E. coli Tat system transports folded proteins containing a conserved 
twin arginine motif within the signal peptide sequence at the N-terminal (48). The signal 
peptide is recognized by the Tat apparatus and is cleaved prior to transport. The Tat 
signal peptide, however, is vulnerable to proteolytic degradation as it is not folded into 
the mature protein (205). Therefore, molecular chaperones bind the signal sequence to 
protect it from proteolysis prior to its recognition by Tat. Specifically, SlyD, GroEL, and 
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Figure 31. Importance of amidase synthesis, transport and activity.  
(top) Survival % of tatC, amiA amiC, envC, dnaK, and ftsEX mutant strains after 
challenged against protamine. (bottom) Schematic illustrating the importance of amidase 
synthesis, transport, and activity mediated by DnaK, Tat, EnvC, and FtsEX. 
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DnaK chaperones have all been demonstrated as Tat signal binding chaperones for an 
array of Tat-dependent substrates (206-208). Therefore, it feasible that DnaK and 
AmiA/AmiC coordinately contribute to bacterial resistance to protamine via DnaK-
mediated protection of AmiA and AmiC transport. Furthermore, it is likely that these 
amidases have a direct role in resistance since alteration of their stability either prior to 
transport via DnaK, during transport via Tat, or during their enzymatic activities via 
EnvC (a functional activator of AmiA (62) or FtsEX (regulators of cell-wall hydrolysis 
that directly recruit EnvC to the septum (63)) increases bacterial susceptibility to 
protamine since deletion of dnaK, tatC, envC, and ftsEX increased bacterial susceptibility 
to protamine (Figure 31).  
Cooperativity of DsbA and DegP in resistance to AMPs. The cooperative contribution of 
DsbA and DegP in the same pathway is obscure. Both DsbA and DegP are involved in 
bacterial pathogenesis by contributing to virulence and intracellular survival, respectively 
(reviewed in (10)). It was recently reported that simultaneous deletion of dsbA and degP 
results in synthetic phenotypes which render cells sensitive to salt and SDS, likely due to 
the increase in membrane permeability (209). Additionally, the double mutant is unable 
to remove unfolded outer membrane proteins from the periplasm resulting in an 
accumulation of OMPs and subsequent activation of σE, a stress-response system that has 
been reported to activate transcription of degP (209). Notably, single deletions of either 
gene rendered cells sensitive to salt and SDS, although at a lower level than the double 
mutant. Thus, it is possible that DsbA and DegP do not contribute directly to bacterial 
resistance to AMPs. Instead, deletion of either gene alters the membrane permeability, 
which results in an increase in protamine susceptibility. Deletion of both genes simply  
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increases the sensitive phenotype. 
CpxR/A activation increases bacterial resistance to antimicrobial peptides 
The data presented in this study suggest a global contribution of the CpxR/A system in 
resistance to AMPs. Therefore, it was hypothesized that activation of the CpxR/A system 
would increase bacterial resistance. Survival of wild-type and ΔcpxR strains harboring a 
vector or pnlpE plasmid were compared to determine if activation of CpxR/A via nlpE 
overexpression could increase Salmonella typhimurium resistance to protamine. Indeed, 
overexpression of nlpE was able to increase bacterial resistance to protamine as 
determined by a 61% survival rate at a lethal protamine concentration for Salmonella 
wild-type cells, 1.8 mg mL
-1
 (Figure 32, top). The increase in resistance was dependent 
on CpxR as deletion of cpxR abolished the increased resistance (Figure 32, top). Further, 
overexpression of nlpE could increase resistance in a ΔtatC mutant in a CpxR-dependent 
manner because cells exhibited a 54% survival rate at a lethal protamine concentration 
for the ΔtatC mutant strain, 1.0 mg mL-1 (Figure 32, middle).  
Other work has demonstrated that overexpression of nlpE can increase resistance of 
several Salmonella protamine susceptible-mutants, including ΔphoP (unpublished data, 
Figure 32, bottom). Therefore, it was not surprising that overexpression of nlpE could 
increase protamine resistance in a ΔtatC mutant strain, suggesting that CpxR/A globally 
contributes to bacterial resistance to protamine. An investigation was initiated to identify 
the CpxR/A-dependent gene(s) that contributes to the increase in resistance.  ΔtolC was 
an obvious candidate as deletion of tolC abolished NlpE-mediated multidrug resistance 
[Nishino et al, 2010]. Both a vector control and pnlpE were introduced into a ΔtolC 
background to determine if overexpression of nlpE could increase resistance to 
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Figure 32. CpxR/A-activation rescues resistance to protamine.  
Overexpression of nlpE can increase protamine resistance of Salmonella (top) wild-type, 
(middle) ΔtatC and (bottom) ΔphoP in a CpxR-dependent manner. Resistance of ΔtolC 
cannot be increased by nlpE overexpression. 
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protamine. As predicted, overexpression of nlpE could not increase resistance in ΔtolC, 
but could in the ΔphoP control (Figure 32, bottom) suggesting that the increase in NlpE-
mediated bacterial resistance to protamine was dependent, at least in part, on TolC. 
Interestingly, overexpression of nlpE appeared to have a cytotoxic affect in the ΔtolC 
strain since protamine susceptibility was increased (Figure 32, bottom). The cytotoxicity 
is proposed to be due to the accumulation of an unknown toxic protamine-influenced 
byproduct that is generally expelled by TolC. 
Conclusion 
The data presented in this study cumulatively identified the CpxR/CpxA two-component 
system as a global regulator that has a significant contribution to bacterial resistance to 
AMPs. Through the upregulation of several loci, CpxR/A can mediate bacterial resistance 
by either actively counteracting the bactericidal effects of AMPs or by playing a 
protective role against AMPs.  
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CHAPTER 5 
DISCUSSION AND FUTURE WORK 
Systematic screen to identify genes required for bacterial resistance to antimicrobial 
peptides 
The data presented here represent the results and subsequent analysis from the first 
reported large-scale, systematic screen to identify Escherichia coli genes that contribute 
to bacterial resistance to antimicrobial peptides (AMPS). The Keio collection (154) of 
~4,000 E. coli single gene deletion mutants was challenged against physiologically 
significant peptides representing –helix and –sheet classes of AMPs, as well as a 
model AMP, to identify mutant strains that were susceptible to the AMPs thus suggesting 
that the gene (or gene product) contributes to resistance. In total, the screen identified 112 
loci (<3% of genes present on the E. coli chromosome) that contributed to resistance to at 
least one analyzed AMP (APPENDIX D) and function in a diverse array of cellular 
processes.  
Surprisingly, most of the mutant strains identified in the analyses were sensitive to only 
one AMP suggesting that the gene indirectly contributes to resistance to that particular 
AMP or that each AMP exerts its bactericidal activity differently. The latter is confirmed 
by previous observations in which different classes of AMPs were shown to exert their 
effects via different mechanisms (as discussed in Introduction). Nevertheless, a 
commonality regarding the bactericidal activity of the AMP or the mechanism of 
resistance was expected. Thus, it was not surprising that two gene products, a transporter 
and an outer membrane component, were found to contribute to bacterial resistance 
against each AMP analyzed. 
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Tat-dependent resistance 
Deletion of tatC, which encodes a major component of the twin-arginine translocation 
(Tat) system rendered cells susceptible to each AMP class, suggesting a global 
contribution to bacterial resistance to AMPs. Further analysis revealed that the Tat-
dependent amidases, AmiA and AmiC, contribute in part to the Tat-dependent resistance. 
The contributions of AmiA and AmiC to resistance are likely to be direct as interference 
in their transport or activity renders cells sensitive to protamine. It remains to be 
determined how AmiA and AmiC contribute to resistance. It can be postulated that the 
positively charged AMP binds to the negatively charged pentapeptide units of the 
peptidoglycan. Thus, AmiA and AmiC facilitate resistance by cleaving the pentapeptide-
AMP complex at its cleavage site (between the N-acetylmuramic acid residue and the 
pentapeptide) to prevent accumulation of the AMP in the periplasm, specifically within 
the peptidoglycan. Further, a periplasmic peptidase/protease could cleave the 
pentapeptide-AMP complex to prevent accumulation in the periplasm which could be 
supported by the observation that a ΔdegP strain is susceptible to protamine. It is unlikely 
that DegP functions cooperatively with AmiA and AmiC since a mutant with a deletion 
of degP in a ΔamiA ΔamiC background was more susceptible to protamine, suggesting 
that amiA/amiC and degP contribute to resistance in independent pathways. 
Alternatively, after being cleaved by the amidases, a transporter could mediate transport 
of the pentapeptide-AMP complex to the cytoplasm for degradation or processing. This 
explanation is supported by previous data which demonstrate that the Salmonella 
YejABEF ABC transporter is required for resistance to many classes of AMPs (152). 
Further studies should be carried out to confirm the functional relationship between the  
119 
amidases and YeJABEF transporter. 
Further analysis regarding Tat-dependent resistance to AMPs implicated two nitrate 
reductases, NapA and YnfF, in bacterial resistance to protamine. Simultaneous deletion 
of napA and ynfF rendered E. coli cells susceptible, indicating that the gene products 
contribute to resistance in concert. Since nitrate is generally reduced in anaerobic 
conditions, it was proposed that the presence of protamine can simulate an anaerobic 
environment by inhibiting the use of oxygen as a final electron acceptor in the electron 
transfer chain, thus disrupting cellular respiration. This is supported by the following 
observations: (i) protamine can inhibit oxygen consumption (189); (ii) deletion of the 
F1F0-ATPase (which abolishes the production of ATP via oxidative phosphorylation) 
increases E. coli susceptibility to protamine presumably due to the inefficient production 
of ATP from substrate-level phosphorylation because supplementation of glucose (which 
should increase the production of ATP via glycolysis) can restore resistance to wild-type 
levels (data not shown); and, (iii) supplementation of formate or succinate, organic acids 
oxidized in the tricarboxylic acid cycle (which should increase the production of ATP via 
substrate-level phosphorylation) is able to protect bacterial cells from the oxygen 
consumption inhibitory effects of  human bactericidal/permeability-increasing protein 
(BPI) and increase bacterial survival in the presence of BPI (170) and protamine (Figure 
2, right). Nevertheless, it remains to be determined how these nitrate-reducing enzymes 
facilitate protamine resistance since exogenous nitrate was not added to the bacteria-
AMP challenge systems. 
Enterobacterial common antigen-dependent resistance 
Deletion of multiple loci residing in the rfe-rff gene cluster was found to cause  
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susceptibility to all peptide classes analyzed, suggesting a global contribution of their 
gene products to AMP resistance. The rfe-rff gene cluster encodes enzymes involved in 
the biosynthesis of the enterobacterial common antigen (ECA), a glycolipid composed of 
a trisaccharide repeat located on the outer leaflet of the outer membrane in all bacteria 
species of the Enterobacteriaceae family (reviewed in (54)). Initial analyses suggested 
that the periplasmic accumulation of intermediates of the ECA biosynthesis pathway was 
responsible for the increased susceptibility to AMPs. This idea was not supported as 
deletion of rfe, which encodes the first enzyme in the pathway and thus inhibits the 
formation of ECA or its intermediates, also rendered cells susceptible to protamine. This 
evidence led to the re-evaluation of previous studies which postulate that accumulation of 
the lipid II intermediate caused susceptibility to bile salt (55). Analysis with each gene 
mutant determined that the absence of ECA and not the accumulation of a specific 
intermediate was the sole reason for increased susceptibility to bile salt. Thus, it appears 
that ECA plays a protective role against host-secreted factors, bile salt and AMPs. It 
remains to be determined how ECA can mediate resistance. Perhaps ECA facilitates 
resistance similarly to lipopolysaccharide (LPS), which are quite similar in regards to the 
biosynthesis and structural components. It may serve as a critical barrier to prevent AMPs 
from reaching the outer membrane to exert their activity. Additional studies should be 
carried out, however, to resolve this mechanism of resistance since ECA appears to be a 
global contributor to bacterial resistance to host-secreted antimicrobial substances. In 
fact, prevous biochemical analyses have shown that protamine can form a complex with 
purified ECA (210) suggesting that ECA can function in bacterial resistance to AMPs by 
binding to AMPs to prevent integration into the cell. 
121 
CpxR/A: a global regulator in E. coli resistance to antimicrobial peptides 
Genetic and biochemical analyses were conducted that identified the CpxR/CpxA two-
component system as a global regulator in bacterial resistance to antimicrobial peptides. 
First, several previously characterized CpxR/A-dependent loci were identified in the 
screen (Table 8), providing initial evidence of the contribution of this system. Next, 
analyses demonstrated that CpxR could activate transcription of amiA and amiC, the 
marRAB operon, as well as, the rfe-rff gene cluster; each of which contributes to E. coli 
resistance to AMPs. It remains to be determined how and why CpxR-dependent 
regulation of these loci contributes to resistance.  
CpxR/A-dependent regulation of amiA and amiC. The CpxR/A system has historically 
been shown to respond to extracytoplasmic stress. For example, in the presence of 
misfolded proteins, CpxR will upregulate the production of proteases that act to reduce 
the load of misfolded proteins. Meanwhile, CpxR will downregulate the production of 
outer membrane proteins which likely are the source of the misfolded proteins. In the 
parameter of AMP resistance, it is known that AMPs can traverse the multiple layers of 
the cell envelope to exert its effect. Certain AMPs, for example LL-37, have been shown 
to translocate the outer membrane and laterally diffuse throughout the periplasm prior to 
crossing the inner membrane (128). It is feasible that during the periplasmic diffusion, 
AMPs disrupt cellular processes carried out in the periplasm and thus cause a stress that 
triggers activation of the CpxR/A system. In this case, AmiA and AmiC may facilitate 
removal of the stress by remodeling the peptidoglycan matrix by reducing the 
accumulation of the AMP bound to the tetrapeptide (as discussed above). 
CpxR/A-dependent regulation of the rfe-rff gene cluster. Deletion of rfe (wecA) or rffA  
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(wecE) has been previously shown to activate transcription of the CpxR/A-dependent 
degP-lac due to accumulation of the ECA lipid II intermediate in the periplasm (55). 
Thus, it was surprising to find that CpxR/A could activate transcription of these genes 
and the others that comprise the rfe-rff gene cluster. The physiological role of the ECA 
has yet to be defined; therefore, it is difficult to ascertain the significance of CpxR/A-
dependent regulation. Since CpxR/A has been shown to mediate bacterial resistance to 
antimicrobial substances, perhaps that upregulation of the ECA facilitates resistance by 
increasing the amount of ECA on the outer membrane to prevent the antimicrobial 
substance from entering the cell. 
CpxR/A-dependent regulation of marRAB. It was not surprising that CpxR/A could 
activate transcription of the marRAB operon. CpxR has previously been shown to 
mediate multridrug resistance by facilitating BaeR-dependent activation of acrD and 
mdtABC promoters to activate the production of xenobiotic efflux pumps (17). 
Additionally, activation of CpxR/A via nlpE overexpression has been shown to increase 
bacterial resistance to antibiotics (18) further positing a significant role for CpxR/A in 
resistance to antimicrobials. The addition of the Mar system to the arsenal of CpxR/A-
mediated resistance mechanisms establishes it as the major regulator in antimicrobial 
resistance since it regulates the sysem previously thought to be the major contributor 
(Mar), as well as Mar-independent systems. 
Cumulatively, this study has identified a multitude of integrated genetic circuitries 
required for bacterial resistance to AMPs (illustrated in Figure 33). This evidence will 
allow for further elucidation of bacterial resistance to host-mediated factors, as well as 
shed insight into the strategies of bacterial survival and adaptation in host environments. 
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Further, it provided additional information regarding the physiological significance of 
several cellular components. 
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Figure 33. Illustration of novel genetic mechanisms required for bacterial resistance to 
the model antimicrobial peptide, protamine.  
Before this dissertation study, PhoP/PhoQ was the only two-component system 
determined to be required for resistance to protamine. Now, an extensive CpxR/A-
dependent circuitry has been uncovered in which CpxR/A-mediates resistance by 
regulating several loci. Dashed line, regulation identified in this study. Solid line, 
regulation previously identified. 
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Strain  Description Reference/Source 
Escherichia coli   
BW25113 
Δ(araD-araB)567 Δlac4787(::rrnB-3) λ− rph-1 
Δ(rhaD-rhaB)568 hsdR514 
(154) 
DH5 
F
−
 supE44 ΔlacU169 
(φ80 lac ΔM15) hsdR17recA1 endA1 
gyrA96 thi-1 relA1 
(211) 
BL21 (DE3)   Stratagene 
Keio collection Keio collection  (154) 
TU190 MG1655 ΔlacIZYA::frt ΔftsEX::KanR (63) 
YS Collection 7 BW25113 acrB::frt emrB::KanR This work 
YS Collection 7 BW25113 acrB::frt acrE::KanR This work 
YS Collection 7 BW25113 acrB::frt emrY::KanR This work 
YS Collection 7 BW25113 acrB::frt glnQ::KanR This work 
YS Collection 7 BW25113 acrB::frt macB::KanR This work 
YS Collection 7 BW25113 acrB::frt mdlB::KanR This work 
YS Collection 7 BW25113 acrB::frt mdtF::KanR This work 
YS Collection 7 BW25113 acrB::frt metN::KanR This work 
YS Collection 7 BW25113 emrB::frt acrB::KanR This work 
YS Collection 7 BW25113 emrB::frt acrE::KanR This work 
YS Collection 7 BW25113 emrB::frt emrY::KanR This work 
YS Collection 7 BW25113 emrB::frt glnQ::KanR This work 
YS Collection 7 BW25113 emrB::frt macB::KanR This work 
YS Collection 7 BW25113 emrB::frt mdlB::KanR This work 
YS Collection 7 BW25113 emrB::frt mdtF::KanR This work 
YS Collection 7 BW25113 emrB::frt metN::KanR This work 
YS Collection 7 BW25113 acrB::frt emrB::frt acrE::KanR This work 
YS Collection 7 BW25113 acrB::frt emrB::frt emrY::KanR This work 
YS Collection 7 BW25113 acrB::frt emrB::frt glnQ::KanR This work 
YS Collection 7 BW25113 acrB::frt emrB::frt macB::KanR This work 
YS Collection 7 BW25113 acrB::frt emrB::frt mdlB::KanR This work 
YS Collection 7 BW25113 acrB::frt emrB::frt mdtF::KanR This work 
YS Collection 7 BW25113 acrB::frt emrB::frt metN::KanR This work 
 BW25113 marA::KanR (154) 
 BW25113 marR::KanR (154) 
 BW25113 marB::KanR (154) 
YS14530 BW25113 marRA::CmR This work 
YS14490 BW25113 cpxR::CmR This work 
 BW25113 rob::KanR (154) 
 BW25113 soxS::KanR (154) 
YS15193 BW25113 rffG::frt rfbB::KanR This work 
YS15189 BW25113 wzzE::frt cld::KanR This work 
YS15191 BW25113 wzzE::frt fepE::KanR This work 
YS13683 BW25113 amiA::frt amiC::frt This work 
142 
Strain  Description Reference/Source 
YS Collection 9 BW25113 amiA::frt amiC::frt citE ::KanR This work 
YS Collection 9 BW25113 amiA::frt amiC::frt fdnG ::KanR This work 
YS Collection 9 BW25113 amiA::frt amiC::frt hyaA ::KanR This work 
YS Collection 9 BW25113 amiA::frt amiC::frt sufI ::KanR This work 
YS Collection 9 
BW25113 amiA::frt amiC::frt 
wcaM ::KanR 
This work 
YS Collection 9 BW25113 amiA::frt amiC::frt yaeI ::KanR This work 
YS Collection 9 BW25113 amiA::frt amiC::frt yagT ::KanR This work 
YS Collection 9 BW25113 amiA::frt amiC::frt yahJ ::KanR This work 
YS Collection 9 BW25113 amiA::frt amiC::frt ybiP ::KanR This work 
YS Collection 9 BW25113 amiA::frt amiC::frt ycbK ::KanR This work 
YS Collection 9 BW25113 amiA::frt amiC::frt yedY ::KanR This work 
YS Collection 9 BW25113 amiA::frt amiC::frt ynfE ::KanR This work 
YS Collection 8 BW25113 napA::frt ynfF ::KanR This work 
YS15226 BW25113 Δrfe-lac lacY+ This work 
YS14891 BW25113 ΔrffT-lac lacY+ This work 
YS15227 BW25113 ΔrffM-lac lacY+ This work 
YS14331 BW25113 ΔmarR-lac lacY+ This work 
YS14329 BW25113 ΔmarA-lac lacY+ This work 
YS14330 BW25113 ΔmarB-lac lacY+ This work 
YS14534 BW25113 ΔmarRA-lac lacY+ This work 
YS11195 BW25113 ΔmgrB-lac lacY+ This work 
TR49 MC4100 λRS88[degP-lac] (200, 201) 
TR50 MC4100 λRS88[cpxP-lac] (55, 201)  
S. enteric serovar 
Typhimurium 
  
14028s wild-type ATCC 
YS13007 14028s ΔtatC::KanR This work 
YS13629 14028s ΔamiA::CmR This work 
YS13630 14028s ΔamiC::CmR This work 
YS13766 14028s ΔamiA ΔamiC::CmR This work 
 YS11590        14028s ΔphoP (212) 
 YS13644      14028s ΔcpxR::CmR This work 
YS13637 14028s ΔamiA-lac lacY+ This work 
YS13640 14028s ΔamiC-lac  lacY+ This work 
YS13995 14028s ΔtatC::frtC ΔcpxR::CmR This work 
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Plasmid  Description Reference/Source 
    pKD3 repR6Kγ Ap
R
 FRT Cm
R
 FRT (155) 
    pKD46 reppSC101
ts
 Ap
R
 ParaBAD γ β exo (155) 
    pCP20 reppSC101
ts
 Ap
R
 Cm
R
 cI857 λPR (155) 
    pCE36 repR6Kγ Km
R
 FRT lacY this (156) 
    pCE37 repR6Kγ Km
R
 FRT lacY this (156) 
pUC19 reppMB1 Ap
R
 (213) 
    pBAD TOPO reppBR322 Ap
R
 araC PBAD Invitrogen 
  pBAD-tatC reppBR322 Ap
R
 araC PBAD tatC This work 
pUHE21–2lacIq reppMB1 Ap
R
 lacI
q
 (157) 
   pUHE-amiA reppMB1 Ap
R
 lacI
q
 amiA This work 
   pUHE-amiC reppMB1 Ap
R
 lacI
q
 amiC This work 
   pUHE-yaeJ reppMB1 Ap
R
 lacI
q
 yaeJ This work 
   pUHE-nlpE reppMB1 Ap
R
 lacI
q
 nlpE This work 
    pET28a repColE1 Km
R
 lacI PT7 Novagen 
   pYS2135 repColE1 Km
R 
lacI PT7 His6-cpxR This work 
pYS1000 repp15A Cm
R
 plac1-6 lac this (158) 
pYS1734 repp15A Cm
R
 plac1-6 lac this marR 5’UTR1-570 This work 
pYS1736 repp15A Cm
R
 plac1-6 lac this marR 5’UTR1-120 This work 
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Number Sequence 
tatC-forward GGGACCGTAAACATGGCTGTA 
tatC-reverse CGGTTGTGTAAAGTCTTCAGT 
232 GAAACAGCTATGACCATG 
233 TTCCCAGTCACGACGTTG 
1327 CGGGATCCTTTTCACAACTCAGGC 
1328 CCCAAGCTTTTACCGTTTCTTCGTG 
1369 CTTGAACTTAATTTTCACAACTCAGGCCGTCATATGAATATCCTCCTTAG 
1370 CTTTCTGATTATCAAACCAGTGAAAATAACGTGTAGGCTGGAGCTGCTTC 
1396 ATCTCTATTTAGTTTTTGCTCGGGAGAAGCCATATGAATATCCTCCTTAG 
1397 CCCGCGCAATAAACTCGCCGTCATCTCAGGGTGTAGGCTGGAGCTGCTTC 
1402 CCCAAGCTTTTGCTCGGGAGAAGC 
1403 CCCAAGCTTAACTTCTTCTCGCCAGCG 
1407 CGTAATTTCTGCCTCGGAGGTACGTAAACACATATGAATATCCTCCTTAG 
1408 TCCTATCATGAAGCGGAAACCATCAGATAGGTGTAGGCTGGAGCTGCTTC 
1413 CGGGATCCTGGCAACAGCCCTCATG 
1414 CCCAAGCTTCAATCCAGTGGACGAC 
1421 CGGGATCCATTTCATAAGGATTTTATGG 
1422 CCCAAGCTTAGTGAGTGCAATCTTTAC 
1461 GTTTAGCCGATTAGCTATAAAGGTGGCGGGCATATGAATATCCTCCTTAG 
1462 CCAGCGGCGATTTGGTTCGCAAGCTGCGGGGTGTAGGCTGGAGCTGCTTC 
1472 TTAGGAGTTTAAAAGTGCTCAT 
1482 ATAAAATTTACGCTTGCACAGA 
1484 CTTCGCCGCCGAGCAT 
1512 GTTTCATATGAATAAAATCCTG 
1513 ACGCGTCGACTCATGAAGCGGAAACCAT 
1567 CAAGATTATGGCGCAAACATCTG 
1595 ATAATGGCGATGTGTCACGTATTCACATGAAAACACATACAATTCTCATCACCAAC 
1598 CTTCTACCAGTTCGGTATGTGGTTCCATGTGCATTGCGCGCCCCACTAG 
1723 TTGCCTGCCAGGCCA 
1725 CAGATCGCTGGTACTTTTCAC 
1731 CCGCTCGTTCATTGAACAGATCGCTGGTACTTTTCAC 
1734 GCGTCGACGCAATATTGGCACTGGGTTCATCTTCCAGC 
1736 GCGTCGACCTTTAGCTAGCCTTGCATCGCATTGAACAA 
1803 GACTGTACTGATTCACG 
1804 CACTTAAGCCGTCGTC 
1912 CTGACAGTGAGTACTGATCTC 
1913 GTGACGTTTGCGGAAGTTTG 
1914 CATTAACCCGCCGTTGCTCG 
1915 CGCGTACCAAATACAGTCAG 
1916 GGCAGCTATCAGGGCGAGCG 
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Number Sequence 
1917 CGCGTAATCGGATGCAATCG 
1919 GGCAACCAGCGTTCCCTGC 
1921 CTGGCAATGACCAAGACCAATGACG 
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Functional Group Gene Name P R 6 30 
 
Survival % Color Code 
  
ATP Synthase 
Subunits 
atpB           <15%     
  atpC           15-30%     
  atpG           30-45%     
  
Biosynthesis/ 
Metabolism 
aroK           45-60%     
  cpsG           60-75%     
  gpmI           75-90%     
  
Cell Wall/ 
Envelope/ Fatty 
Acid Biosynthesis 
amiC           >90%     
  dacA                 
  dadX                 
  envC                 
  fadB                 
  fadR                 
 
lpp                 
 
lpxL                 
 
lpxM                 
 
prc                 
 
rfaD                 
 
yihS                 
 
yqjA                 
 
DNA/RNA 
Synthesis/ 
Degradation/ 
Repair 
amn               
 
deaD                 
 
dnaK                 
 
nfo                 
 
nrdD                 
 
recA                 
 
recJ                 
 
rep                 
 
rimK                 
  rpmF                 
  rpoZ                 
  xerC                 
  xseA                 
  xthA                 
Susceptibility profile of gene mutants whose gene products function in: ATP synthase 
complex; biosynthesis/metabolism; cell wall/envelope/fatty acid biosynthesis; and, 
DNA/RNA biosynthesis/repair. P, protamine; R, RTD-2; 6, OH-CM6; 30, OH-
CATH30. 
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Functional Group Gene Name P R 6 30   Survival % Color Code 
Enterobacterial 
Common Antigen 
(ECA) Synthesis 
rfe           <15%   
rffC           15-30%   
rffH           30-45%   
rffT           45-60%   
Metabolism/ 
Catabolism 
cobS           60-75%   
ilvG           75-90%   
melA           >90%   
menC               
pgm               
ptrB               
ptsG               
ycdM               
yieK               
Regulation 
acnB             
argR               
cpxA               
cpxR               
crp               
feaR               
gcvA               
gcvR               
glnK               
hflD               
lldR               
mak               
pmrD               
ygfZ               
ygiP               
yijO               
yrbA               
rsxB               
Stress Response 
degP               
hfq               
pnp               
yciM               
yeaV               
zwf             
 
Susceptibility profile of gene mutants whose gene products function in: 
enterobacterial common antigen synthesis; metabolism/catabolism; regulation; and, 
stress response. P, protamine; R, RTD-2; 6, OH-CM6; 30, OH-CATH30. 
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Functional Group Gene Name P R 6 30 
 
Survival % Color Code 
 
Transporters/Pores 
alsC 
     
<15% 
  
citT 
     
15-30% 
  
cycA 
     
30-45% 
  
ddpX 
     
45-60% 
  
exbB 
     
60-75% 
  
exuT 
     
75-90% 
  
frlA 
     
>90% 
  
glnQ 
        
gntP 
        
kdpA 
        
mntH 
        
putP 
        
secB 
        
tatA 
        
tatC 
        
tolC 
        
ycjP 
        
yedS 
        
yggR 
        
Other/Unknown 
dsbA 
        
dsbB 
        
flgN 
        
fliI 
        
iscU 
        
ompA 
        
pdxH 
        
spr 
        
yajD 
        
ybhL 
        
yddL 
        
yedN 
        
yehM 
        
yfdI 
        
yfhM 
        
yfjZ 
        
ygeY 
        
yggS 
        
yhjK 
        
yigG 
        
yiiQ 
        
ymgD 
        
ypfN 
        
Susceptibility profiles of gene mutants whose gene products function as: 
transporters/pores and other/unknown functions. P, protamine; R, RTD-2; 6, OH-
CM6; 30, OH-CATH30. 
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Gene 
Name 
CpxR-
Reg 
Function 
Protamine 
R/S 
Ref 
aceE Positive Pyruvate dehydrogenase dihydrolipotransacetylase Resistant (196) 
aceF Positive Pyruvate dehydrogenase dihydrolipotransacetylase Resistant (196) 
acpP ND Fatty acid synthesis, acyl carrier protein Resistant (195) 
acrD Positive Component of efflux pump Resistant (214) 
adhE Negative Ethanol oxioreductase Resistant (195, 196)  
aer Negative Aerotaxis Resistant (214) 
agp Negative Periplasmic glucose-1-phosphatase Resistant (196) 
amiA Positive N-acetylmuramoyl-L-alanine amidase Sensitive (15) 
amiC Positive N-acetylmuramoyl-L-alanine amidase Sensitive (15) 
argA ND N-acetylglutamate synthase Resistant (195) 
ariR (ymgB) Positive Regulator of acid resistance influenced by indole Resistant (196) 
aroG ND DAHP synthase Resistant (214) 
aroK Positive Shikimate kinase I Sensitive (195, 214)  
b2503 ND Putative cytochrome C-type protein Resistant (195) 
b2504 ND Unknown Resistant (195) 
bacA ND Lipid kinase, bacitracin resistance Resistant (195) 
bssR (yliH) Positive Regulator of biofilm formation Resistant (196) 
chaA ND Ca2+/H+ and Na+/H+ antiporter Resistant (195) 
chaB ND Ca2+/H+ and Na+/H+ antiporter Resistant (195) 
cobUST ND Cobalamin synthesis Resistant (195) 
cpxP Positive Inhibitor of CpxA activity Resistant (195, 196, 214) 
cpxRA Positive Signal transduction system Resistant (195, 214)  
csgBAC Negative Curlin fimbriae components Resistant (195, 214)  
csgDEFG ND Curlin fimbriae synthesis and regulation Resistant (195, 214)  
csiR (gabC) Positive Regulator of Gab gene expression  ND (196) 
cspD Negative DNA replication inhibitor Resistant (196) 
csrB Positive Regulatory RNA/carbon storage regulation ND (196) 
degP Positive Periplasmic serine endoprotease Sensitive (195, 214)  
deoC ND Deoxyribse phosphate aldolase Resistant (195) 
dnaK ND σ32-regulated heat shock chaperone Sensitive (195) 
dppC Positive Component of dipeptide ABC transporter Resistant (196) 
dppD Positive Component of dipeptide ABC transporter Resistant (196) 
eda ND 2-Keto-3-deoxy-6-P-gluconate aldolase Resistant (195) 
efeU Negative Elemental ferrous iron uptake permease Resistant (214) 
endA Negative DNA-specific endonuclease I Resistant (196) 
fliA Positive SIgmaF, regulation of flagellar regulon Resistant (196) 
fliY Positive Cystine-binding periplasmic protein Resistant (196) 
flu Positive Antigen 43, potential adhesion OMP Resistant (196) 
fryA (ypdD) Negative fused predicted PTS system Resistant (196) 
ftnB Positive Ferritin-like protein Resistant (196, 214) 
ftsJ-hflB ND Regulates σ32 and lambda cIII degradation Resistant (195) 
fucU Positive L-fucose mutarotase, fucose catabolisme Resistant (196) 
154 
Gene 
Name 
CpxR-
Reg 
Function 
Protamine 
R/S 
Ref 
galP ND Galactose/H+ symporter Resistant (195) 
gatDCBAZY Negative Glactitol specific enzyme component of PTS Resistant (196) 
gcvTHP Negative Glycine-cleavage enzyme system Resistant (195, 196)  
glpA Negative Glycerol-3-phosphate dehydrogenase subunit Resistant (196) 
glpB Negative Glycerol-3-phosphate dehydrogenase subunit Resistant (196) 
glpC Negative Glycerol-3-phosphate dehydrogenase subunit Resistant (196) 
gltK ND Glutamate-aspartate transport Resistant (195) 
gspE Positive General secretory pathway component, cryptic Resistant (196) 
hdhA Negative 7-alpha-hydroxysteroid dehydrogenase Resistant (196) 
hlpA/ompH ND σE controlled periplasmic chaperone Resistant (195) 
hns Positive Global DNA-binding transcriptional dual regulator Resistant (196) 
hslTS ND σ32 regulated heat shock proteins Resistant (195) 
htpX Positive Heat shock protease Resistant (214) 
intB ND Integrase B Resistant (195) 
lamB Negative 
Outer membrane porin; Phage lambda receptor 
protein 
Resistant (196) 
leuS ND Leucyl-tRNA synthetase Resistant (195) 
lgt (umpA) Positive Prolipoprotein diacylglyceryl transferase Resistant (196) 
ligB (yicF) Negative DNA ligase B Resistant (196) 
lpd Positive Lipoamide dehydrogenase Resistant (196) 
manXYZ ND Mannosephosphotransferase system Resistant (195) 
mdtABC Positive Multidrug transporter subunit Resistant (214) 
mobAB ND Guanidine dinucleotide synthesis Resistant (195) 
motAB/cheAW Negative Motility and chemotaxis Resistant (195, 214)  
mviM Positive Virulence factor Resistant (195, 214)  
nanC Positive NAN (N-acetylneuraminic acid) channel Resistant (214) 
ompC Positive Outer membrane porin 1 Resistant (195, 214)  
ompF Negative Outer membrane porin Resistant (195, 214)  
pap Negative Uropathogenic E. coli P pilus subunits Resistant (214) 
pdhR Positive Pyruvate dehydrogenase decarboxylase Resistant (196) 
pepT Negative Peptidase T Resistant (196) 
pheM Positive 
Phenylalanyl-tRNA synthetase (PheST) leader 
peptide 
Resistant (196) 
ppc ND Phosphoenolpyruvate carboxylase Resistant 
 
ppiA Positive Periplasmic peptidyl/prolyl isomerase A Resistant (195, 214)  
ppiD Positive Periplasmic isomerase D Resistant (195, 214)  
psd Positive Phosphatidyl serine decarboxylase Resistant (195, 214)  
pspF Negative Phage-shock protein Resistant (196) 
ptsI ND Enzyme I of PEP:PTS carbohydrate uptake Resistant (195) 
purR ND Regulator purine synthesis Resistant (195) 
puuC (aldH) Positive γ-glutamyl-γ-aminobutyraldehyde dehydrogenase  Resistant (196) 
pykA Negative Pyruvate kinase II/Anaeroic respiration Resistant (196) 
qseB Positive TCS activator of the flagellar regulon Resistant (196) 
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rcsA ND Regulator capsular polysaccharide synthesis Resistant (195) 
rdoA-dsbA Positive Disulfide oxidoreductase Resistant (214) 
rfaY Positive Lipopolysaccharide core biosynthesis protein Resistant (196) 
rffA Positive dTDP-4-oxo-6-deoxy-D-glucose transaminase Sensitive* (196) 
rpoE Positive σE transcription factor  ND (195, 214) 
rpoH ND Heat-shock transcription factor σ32 Resistant (195) 
rpsP ND 30 S ribosomal subunit protein S16 Resistant (195) 
rpsT Negative 30S ribosomal protein S20 Resistant (196) 
rseABC Positive Regulators of σE transcription factor Resistant (195, 214) 
secA Positive Secretion subunit A Resistant (214) 
slt ND Iron regulated Shiga-like toxin Resistant (195) 
smpA Positive Outer membrane lipoprotein Resistant (195, 196) 
spy Positive Periplasmic protein, induced by oxidative stress Resistant (195, 196, 214) 
sspA ND Stringent starvation, adherence and invasion Resistant (195) 
tap ND Taxis toward peptides, methyl-accepting Resistant (195) 
thyA Positive Thymidylate synthetase Resistant (196) 
tig ND Trigger factor with DnaK  Resistant (195) 
tnaA Negative Tryptophan transport and utilization Resistant (196) 
tnaB Negative Tryptophan transport and utilization Resistant (196) 
tnaL (tnaC) Negative Tryptophan transport and utilization Resistant (196) 
tolA Positive Component of the Tol-Pal cell envelope complex Resistant (196) 
tolB Positive Component of the Tol-Pal cell envelope complex Resistant (196) 
tolC Positive Outer membrane pore involved in efflux Sensitive (18) 
tolQ Positive Component of the Tol-Pal cell envelope complex Resistant (196) 
tsr Negative Serine chemoreceptor Resistant (195, 214) 
udk ND Uridine/cytidine kinase Resistant (195) 
ulaR Positive DNA-binding transcriptional dual regulator Resistant (196) 
ung 
Positive/ 
Negative 
Uracil-DNA glycosylase Resistant (195, 214) 
uspA Negative Universal stress global response regulator Resistant (196) 
uxuR ND Represses hexuronate degradation Resistant (195) 
vsr Positive DNA mismatch endocnuclease Resistant (196) 
yafK Positive Conserved protein (periplasmic) Resistant (196) 
ybaJ Positive Unknown Resistant (214) 
ybaQ Positive Predicted transcriptional regulator Resistant (196) 
ybaR ND Putative ATPase Resistant (195) 
ybaS ND Putative glutaminase Resistant (195) 
ybcU (borD) Negative Lipoprotein Bor homolog Resistant (196) 
ybeL Positive Conserved protein Resistant (196) 
ybgC Positive Predicted acyl-coA thioesterase Resistant (196) 
ybgF Positive Component of the Tol-Pal cell envelope complex Resistant (196) 
ybhT Positive Predicted protein Resistant (196) 
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ybjS Positive 
Predicted oxidoreductase with NAD(P) binding 
domain 
Resistant (196) 
ycbZ Negative Putative ATP-dependent protease Resistant (196) 
yccA ND Transmembrane, degraded by FtsH Resistant (195, 196, 214) 
yceI Positive 
Periplasmic protein induced at high pH/osmotic 
shock 
Resistant (196) 
yceJ Positive Predicted cytochrome Resistant (196) 
ycfS Positive Periplasmic protein with unknown function Resistant (214) 
ycgZ Positive Uncharacterized protein Resistant (196) 
yciF Negative Putative structural protein, osmotically inuced Resistant (196) 
ydeH Positive Unknown Resistant (214) 
ydeK Positive Predicted lipoprotein Resistant (196) 
ydeN Negative Uncharacterized sulfatase Resistant (196) 
ydjF Negative Transcriptional regulator Resistant (196) 
yebE Positive Putative inner membrane protein Resistant (214) 
yefJ ND Putative creatinase Resistant (195) 
yfiD ND Putative formate acetyl-transferase Resistant (195) 
ygaW Negative Predicted inner membrane protein Resistant (196) 
ygjT Positive Putative transport protein Resistant (195) 
yhaI Positive Predicted inner membrane protein Resistant (196) 
yhdG ND Probable oxidoreductase, similar NifR3 Resistant (195) 
yhdJ ND Putative methyltransferase Resistant (195) 
yhfC ND Putative transporter Resistant (195) 
yhjE ND Putative transport protein Resistant (195) 
yhjV Positive Inner membrane transport protein Resistant (196) 
yiaF Positive Putative inner membrane lipoprotein Resistant (196) 
yidZ Positive HTH-type transcriptional regulator Resistant (196) 
yihE-dsbA Positive Disulfide oxioreductase Sensitive (195) 
yjfN ND Unknown Resistant (195) 
yjfP ND Unknown Resistant (195) 
yjiY ND Putative carbon starvation protein Resistant (195) 
ymgA Positive Uncharacterized protein Resistant (196) 
yojN ND Putative sensor kinase Resistant (195) 
ypdF Negative aminopeptidase Resistant (196) 
yqjA Positive DedA-like predicted inner membrane protein Sensitive (214) 
yzgL Positive Uncharacterized protein Resistant (196) 
 
 
 
